{"content":"<li class=\"n-box-item date-title\" data-end=\"1464321599\" data-start=\"1464235200\" data-txt=\"Sunday, December 22, 2019\">Thursday, May 26, 2016</li><li class=\"n-box-item sa-box-item\" data-id=\"3185991\" data-ts=\"1464304778\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BHC\" target=\"_blank\">BHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3185991-valeantplus-7_1-on-report-rejected-takeda-tpg-takeover-offer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Valeant +7.1% on report it rejected Takeda, TPG takeover offer</a></h4><ul>   <li>Valeant Pharmaceuticals (VRX) is <font color=\"green\">up 7.1%</font> after hours, following a report from <i>The Wall Street Journal</i> that Takeda (TKPYY) and private-equity firm TPG made a <a href=\"https://twitter.com/DanaMattioli/status/735970013480378368\" target=\"_blank\">combined takeover approach</a> in recent weeks that the company rejected.</li>    <li>No talks are ongoing between the three, though.</li>\n<li>The approach came before Valeant hired Joseph Papa as its new CEO and didn't get to a firm price.</li>\n<li>\n<strong>Updated 7:28 p.m.: </strong>The board wants to <a href=\"http://www.wsj.com/articles/valeant-rejected-joint-takeover-approach-from-takeda-tpg-1464304905\" target=\"_blank\">give Papa time</a> to chart a course for the company, sources told the <em>WSJ.</em>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"3185991\" data-linked=\"Valeant +7.1% on report it rejected Takeda, TPG takeover offer\" data-tweet=\"$BHC $BHC $TAK - Valeant +7.1% on report it rejected Takeda, TPG takeover offer https://seekingalpha.com/news/3185991-valeantplus-7_1-on-report-rejected-takeda-tpg-takeover-offer?source=tweet\" data-url=\"https://seekingalpha.com/news/3185991-valeantplus-7_1-on-report-rejected-takeda-tpg-takeover-offer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>135&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3185985\" data-ts=\"1464302112\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DECK\" target=\"_blank\">DECK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3185985-deckers-outdoor-appoints-new-ceo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deckers Outdoor appoints new CEO</a></h4><ul>     <li>Deckers Outdoor (NASDAQ:<a href=\"https://seekingalpha.com/symbol/DECK\" title=\"Deckers Outdoor Corporation\">DECK</a>) names Dave Powers to the CEO position to replace the retiring Angel Martinez. Martinez will stay on as the chairman of the board.</li>     <li>Though the company topped estimates with its FQ4 report, profit guidance for the upcoming fiscal year arrived weak. Deckers sees FY17 EPS of $4.05 to $4.40 vs. $4.60 consensus.</li>     <li>Previously: <a href=\"https://seekingalpha.com/news/3185931-deckers-outdoor-beats-0_05-beats-revenue\" target=\"_blank\">Deckers Outdoor beats by $0.05, beats on revenue</a> (May 26)</li>     <li>DECK <font color=\"red\">-0.50%</font> AH to $49.01.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3185985\" data-linked=\"Deckers Outdoor appoints new CEO\" data-tweet=\"$DECK - Deckers Outdoor appoints new CEO https://seekingalpha.com/news/3185985-deckers-outdoor-appoints-new-ceo?source=tweet\" data-url=\"https://seekingalpha.com/news/3185985-deckers-outdoor-appoints-new-ceo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:35 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3185983\" data-ts=\"1464301775\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VNDA\" target=\"_blank\">VNDA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3185983-fda-oks-expended-use-of-vandas-fanapt-for-maintenance-treatment-of-schizophrenia-shares-up-5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA OKs expended use of Vanda&#39;s Fanapt for maintenance treatment of schizophrenia; shares up 5% after hours</a></h4><ul>\n<li>Vanda Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/VNDA\" title=\"Vanda Pharmaceuticals Inc.\">VNDA</a>) is up <font color=\"green\">5%</font> after hours on increased volume in response to its announcement that the FDA has approved its supplemental New Drug Application (sNDA) for the use of <a href=\"https://www.fanapt.com/\" target=\"_blank\">Fanapt </a>(iloperidone) as maintenance treatment for adults with schizophrenia.</li>\n<li>The data supporting the application was generated in the REPRIEVE study which showed 79.6% of patients treated with Fanapt remained relapse-free compared to 36.6% for placebo.</li>\n<li>The FDA first <a href=\"http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm149578.htm\" target=\"_blank\">approved </a>Fanapt in May 2009 for the short-term treatment of schizophrenia in adults.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3185983\" data-linked=\"FDA OKs expended use of Vanda&#39;s Fanapt for maintenance treatment of schizophrenia; shares up 5% after hours\" data-tweet=\"$VNDA - FDA OKs expended use of Vanda&#39;s Fanapt for maintenance treatment of schizophrenia; shares up 5% after hours https://seekingalpha.com/news/3185983-fda-oks-expended-use-of-vandas-fanapt-for-maintenance-treatment-of-schizophrenia-shares-up-5?source=tweet\" data-url=\"https://seekingalpha.com/news/3185983-fda-oks-expended-use-of-vandas-fanapt-for-maintenance-treatment-of-schizophrenia-shares-up-5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:29 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3185972\" data-ts=\"1464299206\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PANW\" target=\"_blank\">PANW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3185972-cybersecurity-stocks-slump-after-palo-altos-guidance-disappoints\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cybersecurity stocks slump after Palo Alto&#39;s guidance disappoints</a></h4><ul>\n<li>Several security tech names are selling off after next-gen firewall leader and cybersecurity poster child Palo Alto Networks (<a href=\"https://seekingalpha.com/symbol/PANW\" title=\"Palo Alto Networks\">PANW</a> - <font color=\"red\">down 9.4%</font>) offered <a href=\"https://seekingalpha.com/news/3185939-palo-alto-networks-minus-10_6-percent-despite-record-revenue\" target=\"_blank\">in-line guidance</a> (below consensus at the midpoints) to go with an <a href=\"https://seekingalpha.com/news/3185923-palo-alto-networks-eps-line-beats-revenue\" target=\"_blank\">FQ3 sales beat</a> and in-line EPS, disappointing investors accustomed to seeing Palo Alto provide above-consensus sales guidance with its results.</li>\n<li>Palo Alto's billings rose a solid 61% Y/Y in FQ3, nearly on par with FQ2's 62% growth and outpacing revenue growth of 48%. Product revenue rose 33%, and services revenue (boosted by subscription offerings such as <a href=\"https://www.paloaltonetworks.com/products/secure-the-network/subscriptions/wildfire\" target=\"_blank\">WildFire</a>) 63%. EPS was pressured by a 50% Y/Y increase in GAAP operating expenses to $309.5M.</li>\n<li>FireEye (NASDAQ:<a href=\"https://seekingalpha.com/symbol/FEYE\" title=\"FireEye, Inc.\">FEYE</a>) is <font color=\"red\">down 2%</font> after hours. CyberArk (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CYBR\" title=\"CyberArk Software Ltd.\">CYBR</a>) is <font color=\"red\">down 2.4%</font>. Imperva (NASDAQ:<a href=\"https://seekingalpha.com/symbol/IMPV\" title=\"Imperva, Inc.\">IMPV</a>) is <font color=\"red\">down 1.7%</font>. Fortinet (NASDAQ:<a href=\"https://seekingalpha.com/symbol/FTNT\" title=\"Fortinet, Inc.\">FTNT</a>) is <font color=\"red\">down 1.5%</font>.</li>\n<li>ETF: <a href=\"https://seekingalpha.com/symbol/HACK\" title=\"PureFunds ISE Cyber Security ETF\">HACK</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3185972\" data-linked=\"Cybersecurity stocks slump after Palo Alto&#39;s guidance disappoints\" data-tweet=\"$PANW $PANW $FEYE - Cybersecurity stocks slump after Palo Alto&#39;s guidance disappoints https://seekingalpha.com/news/3185972-cybersecurity-stocks-slump-after-palo-altos-guidance-disappoints?source=tweet\" data-url=\"https://seekingalpha.com/news/3185972-cybersecurity-stocks-slump-after-palo-altos-guidance-disappoints\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3185968\" data-ts=\"1464298785\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3185968-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/VNDA' title='Vanda Pharmaceuticals Inc.'>VNDA</a> <font color='green'>+10.5%</font>. <a href='https://seekingalpha.com/symbol/VEEV' title='Veeva Systems Inc.'>VEEV</a> <font color='green'>+10.1%</font>. <a href='https://seekingalpha.com/symbol/SIEN' title='Sientra'>SIEN</a> <font color='green'>+9.1%</font>. BBG <font color='green'>+9.0%</font>. <a href='https://seekingalpha.com/symbol/ULTA' title='Ulta Beauty, Inc.'>ULTA</a> <font color='green'>+7.7%</font>.</li><li><b>Top losers, as of 5.25p.m.:</b> <a href='https://seekingalpha.com/symbol/CRCM' title='Care.com, Inc.'>CRCM</a> <font color='red'>-9.9%</font>. <a href='https://seekingalpha.com/symbol/PANW' title='Palo Alto Networks'>PANW</a> <font color='red'>-9.3%</font>. <a href='https://seekingalpha.com/symbol/GME' title='GameStop Corp.'>GME</a> <font color='red'>-8.3%</font>. <a href='https://seekingalpha.com/symbol/SPLK' title='Splunk Inc.'>SPLK</a> <font color='red'>-7.3%</font>. <a href='https://seekingalpha.com/symbol/MGPI' title='MGP Ingredients, Inc.'>MGPI</a> <font color='red'>-5.7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3185968\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$VNDA $VEEV $SIEN - After Hours Gainers / Losers https://seekingalpha.com/news/3185968-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3185968-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:39 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3185958\" data-ts=\"1464297044\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPIL\" target=\"_blank\">SPIL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3185958-siliconware-ase-post-huge-gains-after-announcing-merger\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Siliconware, ASE post huge gains after announcing merger</a></h4><ul>\n<li>Taiwanese chip packaging/testing firms Siliconware Precision (<a href=\"https://seekingalpha.com/symbol/SPIL\" title=\"Siliconware Precision Industries Company, Ltd.\">SPIL</a> <font color=\"green\">+10%</font>) and ASE (<a href=\"https://seekingalpha.com/symbol/ASX\" title=\"ASE Technology Holding Co., Ltd.\">ASX</a> <font color=\"green\">+18%</font>) each closed sharply higher after announcing a merger that provides resolution to ASE's <a href=\"https://seekingalpha.com/news/3000246-ase-launches-tender-spil-shares-reiterates-interest-whole-company\" target=\"_blank\">longstanding efforts</a> to acquire Siliconware.</li>\n<li>ASE/Siliconware plan to create a HoldCo that will be listed in Taipei and New York, and own all of the post-merger firm's equity. The HoldCo will issue 0.5 shares for each ASE share, and NT$55/share in cash for each Siliconware share. For reference, Siliconware closed at NT$50.50/share yesterday in Taipei. ASE has already obtained a near-50% stake in Siliconware.</li>\n<li>To appease regulators, each company will continue operating independently under the HoldCo. ASE/Siliconware: \"As parallel sibling companies under HoldCo, ASE and SPIL can, through maintaining an operating model which incentivizes healthy competition while promoting cooperation between the two companies, improve their individual operating efficiencies and economies of scale as well as research innovation achievements.\"</li>\n<li>The companies plan to execute a \"Joint Share Exchange Agreement\" on or before June 25. The deal's closing is subject to the completion of the agreement and regulatory approvals.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3185958\" data-linked=\"Siliconware, ASE post huge gains after announcing merger\" data-tweet=\"$SPIL $SPIL $ASX - Siliconware, ASE post huge gains after announcing merger https://seekingalpha.com/news/3185958-siliconware-ase-post-huge-gains-after-announcing-merger?source=tweet\" data-url=\"https://seekingalpha.com/news/3185958-siliconware-ase-post-huge-gains-after-announcing-merger\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:10 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3185950\" data-ts=\"1464295102\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPLK\" target=\"_blank\">SPLK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3185950-splunkminus-6-despite-revenue-beat-raised-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Splunk -6% despite revenue beat, raised guidance</a></h4><ul>   <li>Splunk (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SPLK\" title=\"Splunk Inc.\">SPLK</a>) is selling off after hours, <font color=\"red\">-6%</font>, after a <a href=\"https://seekingalpha.com/news/3185921-splunk-eps-line-beats-revenue\" target=\"_blank\">Q1 earnings report</a> where a loss came as expected though revenues grew solidly and beat, and the company raised full-year guidance.</li>    <li>It's a \"solid start to the year and we are pleased to welcome more than 450 new customers to the Splunk family,\u201d says CEO Doug Merritt.</li>    <li>The company lost $0.77/share on a GAAP basis; non-GAAP loss was $0.02, in line with expectations.</li>    <li>Revenue breakout: License, $100.99M (up 40.5%); Maintenance and services, $84.96M (up 57.9%).</li>    <li>Operating cash flow of $35.7M; free cash flow was $32M.</li>    <li>For Q2, it sees revenues of $198M-$200M, in line with expectations, and operating margin of 2-3%. It's raising guidance for full-year revenues, to $892M-$896M from its February forecast of $880M (and consensus of $882.3M).</li>     </ul><div class=\"tiny-share-widget\" data-id=\"3185950\" data-linked=\"Splunk -6% despite revenue beat, raised guidance\" data-tweet=\"$SPLK - Splunk -6% despite revenue beat, raised guidance https://seekingalpha.com/news/3185950-splunkminus-6-despite-revenue-beat-raised-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3185950-splunkminus-6-despite-revenue-beat-raised-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3185942\" data-ts=\"1464294298\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GME\" target=\"_blank\">GME</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3185942-gamestop-slumps-after-guidance-disappoints\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GameStop slumps after guidance disappoints</a></h4><ul> <li>GameStop (NYSE:<a href=\"https://seekingalpha.com/symbol/GME\" title=\"GameStop Corp.\">GME</a>) reports same-store sales fell 6.2% in Q1. Sales of new video game hardware fell to 29% Y/Y during the quarter.</li> <li>Revenue mix: New video game hardware $312.9M (15.9% of total), New video game software $567.2M (28.8%), Pre-owned and value video game products  $560.9M (28.5%)      Video game accessories $162.7M (8.2%), Digital $42.8M (2.2%), Mobile and consumer electronics $192.6M (9.8%), Collectibles $82.3M (4.2%).</li> <li>The company's gross profit rate rose 330 bps to 34.3% as diversification with products helped GameStop's bottom line, although the profit view for the rest of the year is below the consensus mark of analysts.</li> <li>GameStop expects FQ2 comparable-store sales to fall between 7% and 4%. Q2 EPS of $0.23-$0.30 is seen vs. $0.31 consensus and full-year EPS of $3.90-$4.05 is forecast vs. $4.00 consensus.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3185928-gamestop-beats-0_05-revenue-line\" target=\"_blank\">GameStop beats by $0.05,  revenue in-line</a> (May 26)</li> <li>GME <font color=\"red\">-10.0%</font> AH to $27.00.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3185942\" data-linked=\"GameStop slumps after guidance disappoints\" data-tweet=\"$GME - GameStop slumps after guidance disappoints https://seekingalpha.com/news/3185942-gamestop-slumps-after-guidance-disappoints?source=tweet\" data-url=\"https://seekingalpha.com/news/3185942-gamestop-slumps-after-guidance-disappoints\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3185939\" data-ts=\"1464293885\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PANW\" target=\"_blank\">PANW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3185939-palo-alto-networksminus-10_6-despite-record-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Palo Alto Networks -10.6% despite record revenue</a></h4><ul>   <li>Palo Alto Networks (NYSE:<a href=\"https://seekingalpha.com/symbol/PANW\" title=\"Palo Alto Networks\">PANW</a>) has <font color=\"red\">slid 10.6%</font> after hours after posting a <a href=\"https://seekingalpha.com/news/3185923-palo-alto-networks-eps-line-beats-revenue\" target=\"_blank\">wider loss in fiscal Q3</a>, though revenue grew by nearly half with the help of new customers in its services unit.</li>    <li>Net loss on a GAAP basis swelled to $70.2M from a year-ago $45.9M. But on a non-GAAP basis, net income grew to $38.5M from the prior $20.5M, after backing out $112.7M in share-based compensation charges.</li>    <li>Billings rose 61% to a record $486.2M. Cash flow from operations was up 95% to $170.1M (margin of 49%); free cash flow also grew 95% to $150.8M (margin of 44%).</li>    <li>Revenue breakout: Product, $162.1M (up 33.4%); Services, $183.7M (up 63%).</li>    <li>For fiscal Q4, it's guiding to revenues of $386M-$390M (growth of 36-37%, and vs. consensus for $389.3M) and non-GAAP EPS of $0.48-$0.50 (vs. consensus for $0.50).</li>    <li>\n<a href=\"http://investors.paloaltonetworks.com\" target=\"_blank\">Conference call</a> to come at 4:30 p.m. ET.</li>     </ul><div class=\"tiny-share-widget\" data-id=\"3185939\" data-linked=\"Palo Alto Networks -10.6% despite record revenue\" data-tweet=\"$PANW - Palo Alto Networks -10.6% despite record revenue https://seekingalpha.com/news/3185939-palo-alto-networksminus-10_6-despite-record-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3185939-palo-alto-networksminus-10_6-despite-record-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3185933\" data-ts=\"1464293507\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ULTA\" target=\"_blank\">ULTA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3185933-ulta-salon-beats-0_16-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ulta Salon beats by $0.16, beats on revenue</a></h4><ul>\n<li>Ulta Salon (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ULTA\" title=\"Ulta Beauty, Inc.\">ULTA</a>): Q1 EPS of $1.45 <font color=\"green\">beats by $0.16</font>.</li>\n<li>Revenue of $1.07B (+23.3% Y/Y) <font color=\"green\">beats by $40M</font>.</li>\n<li>Shares <font color=\"green\">+7.1%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3185933\" data-linked=\"Ulta Salon beats by $0.16, beats on revenue\" data-tweet=\"$ULTA - Ulta Salon beats by $0.16, beats on revenue https://seekingalpha.com/news/3185933-ulta-salon-beats-0_16-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3185933-ulta-salon-beats-0_16-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3185926\" data-ts=\"1464293207\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VEEV\" target=\"_blank\">VEEV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3185926-veeva-systems-beats-0_04-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Veeva Systems beats by $0.04, beats on revenue</a></h4><ul>\n<li>Veeva Systems (NYSE:<a href=\"https://seekingalpha.com/symbol/VEEV\" title=\"Veeva Systems Inc.\">VEEV</a>): FQ1 EPS of $0.15 <font color=\"green\">beats by $0.04</font>.</li>\n<li>Revenue of $119.8M (+33.2% Y/Y) <font color=\"green\">beats by $4.28M</font>.</li>\n<li>Shares <font color=\"green\">+5.5%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3185926\" data-linked=\"Veeva Systems beats by $0.04, beats on revenue\" data-tweet=\"$VEEV - Veeva Systems beats by $0.04, beats on revenue https://seekingalpha.com/news/3185926-veeva-systems-beats-0_04-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3185926-veeva-systems-beats-0_04-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:06 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3185919\" data-ts=\"1464292646\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SDRL\" target=\"_blank\">SDRL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3185919-seadrill-ceo-remarks-suggest-stock-is-grotesquely-overvalued-analyst-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Seadrill CEO remarks suggest stock is &quot;grotesquely overvalued,&quot; analyst says</a></h4><ul>     <li>Seadrill (<a href=\"https://seekingalpha.com/symbol/SDRL\" title=\"Seadrill Limited (New)\">SDRL</a> <font color=\"red\">-7.6%</font>) <a href=\"http://www.bloomberg.com/news/articles/2016-05-05/billionaire-s-bargain-reveals-risks-for-offshore-oil-creditors\" target=\"_blank\">recent purchase</a> of the Cerrado drillship for $65M - less than one tenth of its newbuild cost - still was \u201c<a href=\"http://www.bloomberg.com/news/articles/2016-05-26/billionaire-fredriksen-s-seadrill-says-rig-market-has-bottomed\" target=\"_blank\">probably too much</a>\u201d for a rig that has not worked for a year, CEO Per Wullf says, in remarks that an analyst says \u201cwould suggest that Wullf thinks that his own stock is grotesquely overvalued.\"</li>     <li>\u201cHe\u2019s basically saying that the drilling units are worth about $50 million, or possibly nothing at all, if they haven\u2019t been working recently,\u201d Canaccord's Alex Brooks tells Bloomberg, adding that SDRL\u2019s current share price implies that similar rigs controlled by the company should be valued at ~$175M each.</li>     <li>The Cerrado sale will have no effect on SDRL\u2019s current efforts to restructure nearly $10B in debt, Wullf says.</li>\n<li>Now read <a href=\"https://seekingalpha.com/news/3185872-seadrill-sinks-financing-plan-appears-taking-longer-materialize\" target=\"_blank\"><strong>Seadrill sinks as financing plan \"appears to be taking longer to materialize\"</strong></a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3185919\" data-linked=\"Seadrill CEO remarks suggest stock is &quot;grotesquely overvalued,&quot; analyst says\" data-tweet=\"$SDRL - Seadrill CEO remarks suggest stock is &quot;grotesquely overvalued,&quot; analyst says https://seekingalpha.com/news/3185919-seadrill-ceo-remarks-suggest-stock-is-grotesquely-overvalued-analyst-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3185919-seadrill-ceo-remarks-suggest-stock-is-grotesquely-overvalued-analyst-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3185911\" data-ts=\"1464290556\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BRS\" target=\"_blank\">BRS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3185911-bristow-may-cancel-helicopter-orders-ceo-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bristow may cancel helicopter orders, CEO says</a></h4><ul>     <li>Bristow Group (<a href=\"https://seekingalpha.com/symbol/BRS\" title=\"Bristow Group Inc.\">BRS</a> <font color=\"red\">-28.1%</font>) CEO Jonathan Baliff says for the first time that the helicopter operator <a href=\"http://www.nasdaq.com/article/bristow-sees-drop-in-energyrelated-work-may-cancel-helicopter-orders-20160526-00885\" target=\"_blank\">may cancel some orders for new aircraft</a>, amid expectations for a continuing decline in energy-related work.</li>     <li>In today's earnings conference call, Baliff said the uncertainty has forced BRS to withhold full-year profit guidance, as oil and gas companies cut back on exploration and production, reducing demand for helicopter flights.</li>     <li>The CEO said BRS plans to return some helicopters to lessors when leases expire and has been in talks with manufacturers to defer some deliveries, but that cancellations are a possibility.</li>     <li>BRS gets ~75% of its revenue from the energy industry, and its FQ4 revenue from the sector fell 29% Y/Y; overall revenue for the quarter fell 10% to $375M, well below analyst consensus of $407M (<a href=\"https://seekingalpha.com/news/3185699-bristow-misses-0_38-misses-revenue\" target=\"_blank\">FQ4 earnings</a>).</li>\n<li>Now read <a href=\"https://seekingalpha.com/article/3973431-bristow-group-strong-sell-due-misleading-behavior-looming-covenant-violation-likely\" target=\"_blank\"><strong>Bristow Group: Strong sell due to misleading behavior, looming covenant violation, and likely bankruptcy</strong></a>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"3185911\" data-linked=\"Bristow may cancel helicopter orders, CEO says\" data-tweet=\"$BRS - Bristow may cancel helicopter orders, CEO says https://seekingalpha.com/news/3185911-bristow-may-cancel-helicopter-orders-ceo-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3185911-bristow-may-cancel-helicopter-orders-ceo-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:22 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3185905\" data-ts=\"1464289220\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3185905-technology-top-5-gainers-losers-of-3-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 3:00 pm</a></h4><ul>     <li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/NIHD\" title=\"NII Holdings, Inc.\">NIHD</a> <font color=\"green\">+18%</font>. <a href=\"https://seekingalpha.com/symbol/ASX\" title=\"ASE Technology Holding Co., Ltd.\">ASX</a> <font color=\"green\">+18%</font>. <a href=\"https://seekingalpha.com/symbol/GOGO\" title=\"Gogo\">GOGO</a> <font color=\"green\">+16%</font>. <a href=\"https://seekingalpha.com/symbol/SPIL\" title=\"Siliconware Precision Industries Company, Ltd.\">SPIL</a> <font color=\"green\">+10%</font>.<a href=\"https://seekingalpha.com/symbol/CRCM\" title=\"Care.com, Inc.\">CRCM</a> <font color=\"green\">+9%</font>.</li>\n<li>\n<b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/PSTG\" title=\"Pure Storage\">PSTG</a> <font color=\"red\">-17%</font>. <a href=\"https://seekingalpha.com/symbol/SMT\" title=\"SMART Technologies\">SMT</a> <font color=\"red\">-10%</font>. <a href=\"https://seekingalpha.com/symbol/NETE\" title=\"Net Element International, Inc.\">NETE</a> <font color=\"red\">-9%</font>. <a href=\"https://seekingalpha.com/symbol/VHC\" title=\"VirnetX Holding Corporation\">VHC</a> <font color=\"red\">-8%</font>. <a href=\"https://seekingalpha.com/symbol/RUBI\" title=\"The Rubicon Project, Inc.\">RUBI</a> <font color=\"red\">-7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3185905\" data-linked=\"Technology - Top 5 Gainers / Losers as of 3:00 pm\" data-tweet=\"$NIHD $ASX $GOGO - Technology - Top 5 Gainers / Losers as of 3:00 pm https://seekingalpha.com/news/3185905-technology-top-5-gainers-losers-of-3-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3185905-technology-top-5-gainers-losers-of-3-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3185909\" data-ts=\"1464289155\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FMSA\" target=\"_blank\">FMSA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3185909-fairmount-upgraded-morgan-stanley-amid-increased-frac-sand-conviction\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fairmount upgraded at Morgan Stanley amid increased frac sand conviction</a></h4><ul>     <li>Fairmount Santrol (<a href=\"https://seekingalpha.com/symbol/FMSA\" title=\"Fairmount Santrol, Inc.\">FMSA</a> <font color=\"green\">+10.5%</font>) is <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/16/05/8034594/morgan-stanley-shows-increased-conviction-in-frac-sand-t\" target=\"_blank\">upgraded</a> to Overweight from Equal Weight with a $9 price target at Morgan Stanley, which praises the company's elimination of its debt overhang to 2018-19 vs. 2017.</li>     <li>The firm thinks a refinancing is still required for FMSA, but it sees reason to believe in a much more favorable capital market environment in 2017-18 vs. today.</li>     <li>Stanley reiterates its Overweight rating for U.S. Silica (<a href=\"https://seekingalpha.com/symbol/SLCA\" title=\"U.S. Silica\">SLCA</a> <font color=\"green\">+0.8%</font>) while upping its stock price target to $37 from $33, which sees the company as a potential industry consolidator given its recent equity raise and clean balance sheet, so accretive M&amp;As could lend near-term upside to shares.</li>\n<li>FMSA, which was upgraded <a href=\"https://seekingalpha.com/news/3185095-fmsa-upgraded-rbc-increasing-proppant-intensity\" target=\"_blank\">earlier in the week</a> at RBC Capital, has climbed 40% this week.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3185909\" data-linked=\"Fairmount upgraded at Morgan Stanley amid increased frac sand conviction\" data-tweet=\"$FMSA $FMSA $SLCA - Fairmount upgraded at Morgan Stanley amid increased frac sand conviction https://seekingalpha.com/news/3185909-fairmount-upgraded-morgan-stanley-amid-increased-frac-sand-conviction?source=tweet\" data-url=\"https://seekingalpha.com/news/3185909-fairmount-upgraded-morgan-stanley-amid-increased-frac-sand-conviction\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3185900\" data-ts=\"1464288131\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PAA\" target=\"_blank\">PAA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3185900-investors-worry-plains-all-american-fold-in-mlp\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Investors worry that Plains All American could fold in MLP</a></h4><ul>     <li>Little was said at today's investor day on the subject, but <em>Barron's</em> Amey Stone suspects <a href=\"http://blogs.barrons.com/incomeinvesting/2016/05/26/potential-for-plains-to-fold-in-mlp-has-investors-worried/?mod=BOL_hp_blog_ii\" target=\"_blank\">investors are nervous</a> that Plains All American Pipeline (<a href=\"https://seekingalpha.com/symbol/PAA\" title=\"Plains All American Pipeline, L.P.\">PAA</a> <font color=\"red\">-1.7%</font>) may consolidate its MLP with the general partner, Plains GP Holdings (<a href=\"https://seekingalpha.com/symbol/PAGP\" title=\"Plains GP Holdings, LP\">PAGP</a> <font color=\"red\">-2.9%</font>).</li>     <li>One worry about a potential consolidation is that it will threaten the high distributions of the MLP, Wunderlich's Jeff Birnbaum says, and long-term holders also would worry about tax consequences in a restructuring.</li>     <li>Birnbaum believes a deal would improve Plains\u2019 financial outlook, \"but choices will likely need to be made between PAA\u2019s distribution and leverage,\" so he awaits a more attractive entry point alongside additional signs of upcoming volume growth.</li>     <li>Now read <a href=\"https://seekingalpha.com/news/3185882-plains-american-pipeline-plains-gp-kept-neutral-credit-suisse\" target=\"_blank\"><strong>Plains All American Pipeline, Plains GP kept Neutral at Credit Suisse</strong></a>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"3185900\" data-linked=\"Investors worry that Plains All American could fold in MLP\" data-tweet=\"$PAA $PAA $PAGP - Investors worry that Plains All American could fold in MLP https://seekingalpha.com/news/3185900-investors-worry-plains-all-american-fold-in-mlp?source=tweet\" data-url=\"https://seekingalpha.com/news/3185900-investors-worry-plains-all-american-fold-in-mlp\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3185898\" data-ts=\"1464287402\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DG\" target=\"_blank\">DG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3185898-discounters-out-of-amazons-shadow-make-gains\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Discounters out of Amazon&#39;s shadow make gains</a></h4><ul> <li>Discounters are rallying in full force after Dollar General (<a href=\"https://seekingalpha.com/symbol/DG\" title=\"Dollar General Corporation\">DG</a> <font color=\"green\">+4.6%</font>) and Dollar Tree (<a href=\"https://seekingalpha.com/symbol/DLTR\" title=\"Dollar Tree, Inc.\">DLTR</a> <font color=\"green\">+12.5%</font>) both posted Q1 profit ahead of expectations.</li> <li>Steady consumer demand, tight expense control, and an easing of promotional pressure underpinned both reports.</li>\n<li>Retail Dive may have arrived at the heart of the matter, by noting that dollar stores attract different shoppers than the retailers which have been ravaged by Amazon's growth.</li> <li>\"We are part of what I consider, in this economic environment, the most attractive sector in retail,\" said Dollar Tree CEO Bob Sasser.</li> <li>Investors seem to agree. Ollie's Bargain Outlet Holdings (<a href=\"https://seekingalpha.com/symbol/OLLI\" title=\"Ollie's Bargain Outlet Holdings\">OLLI</a> <font color=\"green\">+7.6%</font>), Burlington Stores (<a href=\"https://seekingalpha.com/symbol/BURL\" title=\"Burlington Stores, Inc\">BURL</a> <font color=\"green\">+7.8%</font>), Big Lots (<a href=\"https://seekingalpha.com/symbol/BIG\" title=\"Big Lots, Inc.\">BIG</a> <font color=\"green\">+2.7%</font>), Five Below (<a href=\"https://seekingalpha.com/symbol/FIVE\" title=\"Five Below\">FIVE</a> <font color=\"green\">+2.9%</font>), Ross Stores (<a href=\"https://seekingalpha.com/symbol/ROST\" title=\"Ross Stores, Inc.\">ROST</a> <font color=\"green\">+0.9%</font>), TJX Companies (<a href=\"https://seekingalpha.com/symbol/TJX\" title=\"TJX Companies Inc.\">TJX</a> <font color=\"green\">+1%</font>), Tuesday Morning (<a href=\"https://seekingalpha.com/symbol/TUES\" title=\"Tuesday Morning Corp.\">TUES</a> <font color=\"green\">+1.9%</font>), and Fred's (<a href=\"https://seekingalpha.com/symbol/FRED\" title=\"Fred's, Inc.\">FRED</a> <font color=\"green\">+6.2%</font>) are all pushing higher.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3185898\" data-linked=\"Discounters out of Amazon&#39;s shadow make gains\" data-tweet=\"$DG $DG $DLTR - Discounters out of Amazon&#39;s shadow make gains https://seekingalpha.com/news/3185898-discounters-out-of-amazons-shadow-make-gains?source=tweet\" data-url=\"https://seekingalpha.com/news/3185898-discounters-out-of-amazons-shadow-make-gains\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3185897\" data-ts=\"1464286796\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TDW\" target=\"_blank\">TDW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3185897-tidewaterminus-33-on-dismal-quarter-warning-of-possible-covenant-breach\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tidewater -33% on dismal quarter, warning of possible covenant breach</a></h4><ul>     <li>Tidewater (<a href='https://seekingalpha.com/symbol/TDW' title='Tidewater, Inc.'>TDW</a> <font color='red'>-33.6%</font>) is today's biggest loser among energy stocks after posting a much larger than expected <a href=\"https://seekingalpha.com/news/3185680-tidewater-eps-1_74\" target=\"_blank\">Q1 loss</a> and warning of a possible covenant breach.</li>     <li>TDW says that by June 30 it may no longer be in compliance with the 3x minimum interest coverage ratio requirement under its loan agreements.</li>     <li>TDW says its FY&nbsp;2016 (ended March 31) statements likely will include a \"going concern\"&nbsp;paragraph since its internal forecast indicates that within FY 2017 the company may no longer be in compliance with the minimum interest coverage ratio requirement.</li>     <li>During today's earnings conference call, CFO Quinn Fanning said TDW <a href=\"https://www.thestreet.com/story/13586587/1/tidewater-stock-falls-on-missed-earnings-possible-covenant-breach.html\" target=\"_blank\">may be required to give concessions</a> to its lenders to successfully secure amendments to its credit facility, which could include a reduced borrowing base or granting the lenders collateral.</li>     <li>Now read <a href=\"https://seekingalpha.com/article/3977946-will-looming-minor-credit-covenant-breach-force-tidewater-bankruptcy\" target=\"_blank\"><strong>Will a looming minor credit covenant breach force Tidewater into bankruptcy?</strong></a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3185897\" data-linked=\"Tidewater -33% on dismal quarter, warning of possible covenant breach\" data-tweet=\"$TDW - Tidewater -33% on dismal quarter, warning of possible covenant breach https://seekingalpha.com/news/3185897-tidewaterminus-33-on-dismal-quarter-warning-of-possible-covenant-breach?source=tweet\" data-url=\"https://seekingalpha.com/news/3185897-tidewaterminus-33-on-dismal-quarter-warning-of-possible-covenant-breach\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3185896\" data-ts=\"1464286455\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NYRT\" target=\"_blank\">NYRT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3185896-new-york-reit-investors-not-pleased-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New York REIT investors not pleased with sale</a></h4><ul>\n<li>\"The jury is out and New York REIT\u2019s (<a href=\"https://seekingalpha.com/symbol/NYRT\" title=\"New York REIT\">NYRT</a> <font color=\"red\">-8%</font>) board owes its shareholders a lot more transparency quantitatively <a href=\"http://www.moneyweb.co.za/news-fast-news/new-york-reit-shares-plunge-analysts-question-acquisition/\" target=\"_blank\">why this transaction is better</a> than all viable alternatives in the short, medium and long term,\u201d says Evercore ISI's Sheila McGrath.</li>\n<li>A \"very rough analysis\" points to  material dilution in NAV for NYRT shareholders, says SunTrust's Michael Lewis.</li>\n<li>Yet to be heard from are activist owners Jonathan Litt and Michael Ashner, who had been urging an overhaul of the board and the sale of properties to help boost shareholder value.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3185754-new-york-reit-jbg-companies-create-nyc-dc-reit\" target=\"_blank\">New York REIT and JBG Companies to create NYC/DC REIT</a> (May 26)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3185896\" data-linked=\"New York REIT investors not pleased with sale\" data-tweet=\"$NYRT - New York REIT investors not pleased with sale https://seekingalpha.com/news/3185896-new-york-reit-investors-not-pleased-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/3185896-new-york-reit-investors-not-pleased-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3185891\" data-ts=\"1464285626\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3185891-energy-materials-top-5-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm</a></h4><ul> <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/EMES' title='Emerge Energy Services LP'>EMES</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/ERN' title='Erin Energy Corp.'>ERN</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/PES' title='Pioneer Energy Services'>PES</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/ROYT' title='Pacific Coast Oil Trust'>ROYT</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/TANH' title='Tantech Holdings'>TANH</a> <font color='green'>+9%</font>.</li> <li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/TDW' title='Tidewater, Inc.'>TDW</a> <font color='red'>-34%</font>. <a href='https://seekingalpha.com/symbol/BRS' title='Bristow Group Inc.'>BRS</a> <font color='red'>-27%</font>. <a href='https://seekingalpha.com/symbol/VHI' title='Valhi, Inc.'>VHI</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/GLF' title='GulfMark Offshore, Inc.'>GLF</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/ATW' title='Atwood Oceanics Inc.'>ATW</a> <font color='red'>-9%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3185891\" data-linked=\"Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm\" data-tweet=\"$EMES $ERN $PES - Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3185891-energy-materials-top-5-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3185891-energy-materials-top-5-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3185890\" data-ts=\"1464284930\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IGT\" target=\"_blank\">IGT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3185890-igtplus-1_6-after-profits-beat-on-strong-global-lotto-growth\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IGT +1.6% after profits beat on strong global lotto growth</a></h4><ul>   <li>International Game Technology (NYSE:<a href=\"https://seekingalpha.com/symbol/IGT\" title=\"International Game Technology\">IGT</a>) is <font color=\"green\">up 1.6%</font> to its highest point in a month after a <a href=\"https://seekingalpha.com/news/3185728-international-game-technology-beats-0_09-revenue-line\" target=\"_blank\">Q1 profit beat</a> where revenues rose on a reported and pro forma basis.</li>    <li>Global lottery growth was strong and the company won a key Italian Lotto concession, one of its biggest contracts.</li>    <li>Revenue breakout: Service, $1.135B (up 43.6%); Product sales, $146.4M (up 152.6%). The April 7, 2015, combination of GTECH and IGT affected comparability. By segment (pro forma basis): North America Gaming &amp; Interactive was flat, North America Lottery revenue was up 16%, International revenue fell 2%, and Italy revenue rose 2.3%.</li>    <li>It reiterated guidance of EBITDA of $1.74B-$1.79B for the full year (in line) against modest currency headwinds, and capex excluding Lotto concessions of $575M-$625M.</li>    <li>The company will hold its investor day June 21-22.</li>    <li><a href=\"https://seekingalpha.com/article/3978032-international-game-technologys-igt-ceo-marco-sala-q1-2016-results-earnings-call-transcript\" target=\"_blank\">Earnings call transcript</a></li>     </ul><div class=\"tiny-share-widget\" data-id=\"3185890\" data-linked=\"IGT +1.6% after profits beat on strong global lotto growth\" data-tweet=\"$IGT - IGT +1.6% after profits beat on strong global lotto growth https://seekingalpha.com/news/3185890-igtplus-1_6-after-profits-beat-on-strong-global-lotto-growth?source=tweet\" data-url=\"https://seekingalpha.com/news/3185890-igtplus-1_6-after-profits-beat-on-strong-global-lotto-growth\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:48 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3185885\" data-ts=\"1464282832\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WBMD\" target=\"_blank\">WBMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3185885-webmd-slumps-after-pricing-300m-convertible-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WebMD slumps after pricing $300M convertible offering</a></h4><ul>\n<li>WebMD (<a href=\"https://seekingalpha.com/symbol/WBMD\" title=\"WebMD Health Corp\">WBMD</a> <font color=\"red\">-5.9%</font>) is selling $300M worth of convertible notes due 2023. The notes carry a 2.625% interest rate, and a conversion price of $87.07 (38% above current levels).</li>\n<li>Net proceeds will be used for \"general corporate purposes, which may include acquisitions, repurchases of WebMD common stock, repurchases of outstanding convertible notes and for working capital.\" WebMD had $593M in cash and $700M in convertible debt at the end of Q1. $397M worth of convertible notes were due in 2018, and $295M due in 2020.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3185885\" data-linked=\"WebMD slumps after pricing $300M convertible offering\" data-tweet=\"$WBMD - WebMD slumps after pricing $300M convertible offering https://seekingalpha.com/news/3185885-webmd-slumps-after-pricing-300m-convertible-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3185885-webmd-slumps-after-pricing-300m-convertible-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:13 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3185884\" data-ts=\"1464282684\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/X\" target=\"_blank\">X</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3185884-u-s-steel-channel-checks-imply-profit-upside-rosenblatt-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">U.S. Steel channel checks imply profit upside, Rosenblatt says</a></h4><ul>     <li>U.S. Steel (<a href=\"https://seekingalpha.com/symbol/X\" title=\"United States Steel Corporation\">X</a> <font color=\"green\">+2.7%</font>) is reiterated with a <a href=\"http://www.streetinsider.com/Analyst+Comments/US+Steel+Corp+%28X%29%3A+Channel+Checks+Imply+Profit+Upside+-+Rosenblatt/11677751.html\" target=\"_blank\">Buy rating</a> and $25 price target at Rosenblatt, which says its series of channel checks indicates the company is on-track to generate $500M-$525M of total EBITDA in 2016.</li>     <li>The firm expects X to raise its full-year EBITDA target by $100M-$125M based on the continued strength in domestic carbon sheet pricing, anticipated cost savings from Carnegie Way, and new evidence of slowly improving trends in the tubular markets.</li>     <li>Rosenblatt also raises its 2017 EPS forecast by $0.46 to $0.30 in anticipation of favorable annual steel contract adjustments and reduced losses for the tubular segment.</li>\n<li>Now read <a href=\"https://seekingalpha.com/news/3185776-u-s-slaps-hefty-duties-chinese-corrosion-resistant-steel\" target=\"_blank\"><strong>U.S. slaps heavy duties on Chinese corrosion-resistant steel</strong></a>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"3185884\" data-linked=\"U.S. Steel channel checks imply profit upside, Rosenblatt says\" data-tweet=\"$X - U.S. Steel channel checks imply profit upside, Rosenblatt says https://seekingalpha.com/news/3185884-u-s-steel-channel-checks-imply-profit-upside-rosenblatt-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3185884-u-s-steel-channel-checks-imply-profit-upside-rosenblatt-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3185880\" data-ts=\"1464282016\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3185880-financials-top-5-gainers-losers-of-1-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/AAMC' title='Altisource Asset Management Corp'>AAMC</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> FXCM <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/NYRT' title='New York REIT'>NYRT</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/SBSI' title='Southside Bancshares, Inc.'>SBSI</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3185880\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM\" data-tweet=\"$AAMC $GLBR $NYRT - Financials - Top 5 Gainers / Losers as of 1:00 PM https://seekingalpha.com/news/3185880-financials-top-5-gainers-losers-of-1-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3185880-financials-top-5-gainers-losers-of-1-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3185878\" data-ts=\"1464281953\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3185878-universal-display-hits-52-week-high-analysts-keep-raving\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Universal Display hits 52-week high as analysts keep raving</a></h4><ul>   <li>Universal Display is <font color=\"green\">up 1.7%</font> today and setting a new 52-week high as positive analyst sentiment continues to roll in -- this time with Cowen, reacting to Display Week with a higher price target.</li>    <li>The firm's Robert Stone raised his target to $75, from $65, implying another 12% upside from today's higher price. Stone reiterated an Outperform rating.</li>    <li>He sees <a href=\"http://blogs.barrons.com/techtraderdaily/2016/05/26/universal-display-cowen-ups-target-to-75-on-further-oled-trends/\" target=\"_blank\">more evidence of share gains</a> for the display maker and pointed to Universal's customer presentations when it comes to emphasizing AMOLED, \"especially flexible displays, for future product designs in mobile and automotive. AMOLED is also key to immersive VR. New designs and categories are critical amid slowing/declining sales of smartphones, tablets and PCs.\"</li>    <li>Needham &amp; Co. has also boosted its price target on the stock, to $69 from $62. On Monday, Goldman Sachs <a href=\"https://seekingalpha.com/news/3185026-universal-display-soars-apple-related-goldman-upgrade\" target=\"_blank\">upgraded the stock</a> to Buy with a $76 price target.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3185878\" data-linked=\"Universal Display hits 52-week high as analysts keep raving\" data-tweet=\"Universal Display hits 52-week high as analysts keep raving https://seekingalpha.com/news/3185878-universal-display-hits-52-week-high-analysts-keep-raving?source=tweet\" data-url=\"https://seekingalpha.com/news/3185878-universal-display-hits-52-week-high-analysts-keep-raving\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3185873\" data-ts=\"1464281112\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3185873-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/NERV\" title=\"Minerva Neurosciences\">NERV</a> <font color=\"green\">+163%</font>. <a href=\"https://seekingalpha.com/symbol/FLXN\" title=\"Flexion Therapeutics, Inc.\">FLXN</a> <font color=\"green\">+37%</font>. <a href=\"https://seekingalpha.com/symbol/SKIS\" title=\"Peak Resorts\">SKIS</a> <font color=\"green\">+29%</font>. <a href=\"https://seekingalpha.com/symbol/BBSI\" title=\"Barrett Business Services, Inc.\">BBSI</a> <font color=\"green\">+28%</font>. <a href=\"https://seekingalpha.com/symbol/GOGO\" title=\"Gogo\">GOGO</a> <font color=\"green\">+20%</font>. <a href=\"https://seekingalpha.com/symbol/NIHD\" title=\"NII Holdings, Inc.\">NIHD</a> <font color=\"green\">+19%</font>. <a href=\"https://seekingalpha.com/symbol/ASX\" title=\"ASE Technology Holding Co., Ltd.\">ASX</a> <font color=\"green\">+17%</font>. EBIO <font color=\"green\">+16%</font>. <a href=\"https://seekingalpha.com/symbol/ROSG-OLD\" title=\"Rosetta Genomics Ltd.\">ROSG-OLD</a> <font color=\"green\">+14%</font>. <a href=\"https://seekingalpha.com/symbol/DLTR\" title=\"Dollar Tree, Inc.\">DLTR</a> <font color=\"green\">+13%</font>.</li>\n<li>\n<b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/IONS\" title=\"Ionis Pharmaceuticals, Inc.\">IONS</a> <font color=\"red\">-39%</font>. PRGN <font color=\"red\">-35%</font>. <a href=\"https://seekingalpha.com/symbol/TDW\" title=\"Tidewater, Inc.\">TDW</a> <font color=\"red\">-33%</font>. <a href=\"https://seekingalpha.com/symbol/OVAS-OLD\" title=\"OvaScience, Inc.\">OVAS-OLD</a> <font color=\"red\">-30%</font>. <a href=\"https://seekingalpha.com/symbol/BRS\" title=\"Bristow Group Inc.\">BRS</a> <font color=\"red\">-20%</font>. <a href=\"https://seekingalpha.com/symbol/PSTG\" title=\"Pure Storage\">PSTG</a> <font color=\"red\">-18%</font>. <a href=\"https://seekingalpha.com/symbol/ANF\" title=\"Abercrombie &amp; Fitch\">ANF</a> <font color=\"red\">-18%</font>. <a href=\"https://seekingalpha.com/symbol/GBSN-OLD\" title=\"Great Basin Scientific, Inc.\">GBSN</a> <font color=\"red\">-17%</font>. <a href=\"https://seekingalpha.com/symbol/SPEX\" title=\"Spherix Incorporated\">SPEX</a> <font color=\"red\">-15%</font>. <a href=\"https://seekingalpha.com/symbol/KOOL\" title=\"Cesca Therapeutics Inc\">KOOL</a> <font color=\"red\">-14%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3185873\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$NERV $FLXN $SKIS - Midday Gainers / Losers https://seekingalpha.com/news/3185873-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3185873-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3185872\" data-ts=\"1464281041\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SDRL\" target=\"_blank\">SDRL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3185872-seadrill-sinks-financing-plan-appears-to-be-taking-longer-to-materialize\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Seadrill sinks as financing plan &quot;appears to be taking longer to materialize&quot;</a></h4><ul>     <li>Seadrill (<a href=\"https://seekingalpha.com/symbol/SDRL\" title=\"Seadrill Limited (New)\">SDRL</a> <font color=\"red\">-6.4%</font>) surrenders <a href=\"https://seekingalpha.com/news/3185792-seadrill-q1-profits-revenues-plunge-scores-record-operational-uptime\" target=\"_blank\">strong premarket gains</a> and shares now trade more than 6% lower, as Wells Fargo analysts say SDRL\u2019s \u201c<a href=\"http://blogs.barrons.com/stockstowatchtoday/2016/05/26/why-seadrill-is-sinking/\" target=\"_blank\">financing plan announcement appears to be taking longer to materialize</a>.\u201d</li>     <li>Wells says SDRL's recurring Q1 EPS of $0.26 came in below its expectations of $0.37 and consensus of $0.39, primarily driven by higher taxes; <a href=\"https://seekingalpha.com/news/3185718-seadrill-eps-0_15\" target=\"_blank\">reported EPS of $0.15</a> included ~$0.11 of charges for impairments and derivatives.</li>     <li>The firm views the Q1 report as neutral to modestly positive but notes a lack of additional near-term disclosure on SDRL's pending debt refinancing and restructuring plans, and thinks the originally expected late Q2 financing plan appears to be taking longer to materialize, with the company now expecting to finish and execute its plans by year end.</li>\n<li>Now read <a href=\"https://seekingalpha.com/article/3977972-seadrill-q1-2016-results-review-nutshell\" target=\"_blank\"><strong>Seadrill: Q1 2016 results review in a nutshell</strong></a>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"3185872\" data-linked=\"Seadrill sinks as financing plan &quot;appears to be taking longer to materialize&quot;\" data-tweet=\"$SDRL - Seadrill sinks as financing plan &quot;appears to be taking longer to materialize&quot; https://seekingalpha.com/news/3185872-seadrill-sinks-financing-plan-appears-to-be-taking-longer-to-materialize?source=tweet\" data-url=\"https://seekingalpha.com/news/3185872-seadrill-sinks-financing-plan-appears-to-be-taking-longer-to-materialize\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3185869\" data-ts=\"1464280173\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IONS\" target=\"_blank\">IONS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3185869-ionis-pain-is-alnylams-gain-shares-up-13\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ionis&#39; pain is Alnylam&#39;s gain, shares up 13%</a></h4><ul>\n<li>Ionis Pharmaceuticals' (<a href=\"https://seekingalpha.com/symbol/IONS\" title=\"Ionis Pharmaceuticals, Inc.\">IONS</a> <font color=\"red\">-38%</font>) hiccup related to its antisense drug candidate for familial amyloidotic polyneuropathy (FAP), IONIS-TTRrx, stokes buying in RNA interference (RNAi) therapeutics developer Alnylam Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/ALNY\" title=\"Alnylam Pharmaceuticals, Inc.\">ALNY</a> <font color=\"green\">+13%</font>) who is developing its own FAP candidate called patisiran which recently showed positive results in a Phase 2 study.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3174171-alnylams-patisiran-shows-treatment-benefit-mid-stage-study-rare-inherited-disorder\" target=\"_blank\">Alnylam's patisiran shows treatment benefit in mid-stage study in rare inherited disorder</a> (April 20)</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3185767-glaxo-declines-proceed-late-stage-study-ionis-pharmas-ionis-ttrrx-ionis-7-percent-premarket\" target=\"_blank\">Glaxo declines to proceed with late-stage study of Ionis Pharma's IONIS-TTRrx; Ionis down 7% premarket</a> (May 26)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3185869\" data-linked=\"Ionis&#39; pain is Alnylam&#39;s gain, shares up 13%\" data-tweet=\"$IONS $IONS $ALNY - Ionis&#39; pain is Alnylam&#39;s gain, shares up 13% https://seekingalpha.com/news/3185869-ionis-pain-is-alnylams-gain-shares-up-13?source=tweet\" data-url=\"https://seekingalpha.com/news/3185869-ionis-pain-is-alnylams-gain-shares-up-13\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3185861\" data-ts=\"1464278430\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3185861-consumer-goods-top-gainers-losers-of-12-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer Goods - Top Gainers / Losers as of 12:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/GIII' title='G-III Apparel Group, LTD.'>GIII</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/MOV' title='Movado Group, Inc.'>MOV</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/MOD' title='Modine Manufacturing Company'>MOD</a> <font color='red'>-6%</font>. SPU <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3185861\" data-linked=\"Consumer Goods - Top Gainers / Losers as of 12:00 am\" data-tweet=\"$GIII $MOV $MOD - Consumer Goods - Top Gainers / Losers as of 12:00 am https://seekingalpha.com/news/3185861-consumer-goods-top-gainers-losers-of-12-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3185861-consumer-goods-top-gainers-losers-of-12-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3185860\" data-ts=\"1464278153\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/USDP\" target=\"_blank\">USDP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3185860-usd-partners-cut-to-neutral-from-buy-citi\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">USD Partners cut to Neutral from Buy at Citi</a></h4><ul>     <li>USD Partners (<a href=\"https://seekingalpha.com/symbol/USDP\" title=\"USD Partners LP\">USDP</a> <font color=\"red\">-3.9%</font>) is <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/16/05/8034523/citi-downgrades-usd-partners-to-neutral-cites-near-term-\" target=\"_blank\">downgraded</a> to Neutral from Buy with a $10.50 price target at Citigroup, which says near-term operations are stable but the long-term looks risky.</li>     <li>Citi views USDP's near-term cash flows as stable and should provide investors adequate distribution coverage with minimal risk, but in light of continued low crude spreads and additional pipeline capacity coming online over the next few years, the firm thinks that signing new shippers to long-term terminalling contracts could prove challenging.</li>     <li>While the firm believes that rail capacity will be an integral long-term part of crude logistics infrastructure, the amount of terminal capacity required is difficult to estimate.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3185860\" data-linked=\"USD Partners cut to Neutral from Buy at Citi\" data-tweet=\"$USDP - USD Partners cut to Neutral from Buy at Citi https://seekingalpha.com/news/3185860-usd-partners-cut-to-neutral-from-buy-citi?source=tweet\" data-url=\"https://seekingalpha.com/news/3185860-usd-partners-cut-to-neutral-from-buy-citi\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3185854\" data-ts=\"1464277942\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALBO\" target=\"_blank\">ALBO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3185854-biodel-completes-round-trip-related-to-albireo-merger-shares-down-14\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Biodel completes round trip related to Albireo merger; shares down 14%</a></h4><ul>\n<li>Nano cap Biodel (BIOD <font color=\"red\">-14.3%</font>) gives all its merger news pop back as shares have completely retraced from yesterday's up move which was over 40% at one time but failed to hold.</li>\n<li>Tuesday evening, the company announced that it would combine with privately held <a href=\"http://www.albireopharma.com/\" target=\"_blank\">Albireo</a>. The new company will do business as Albireo Pharma and trade under the symbol \"ALBO.\" A syndicate of institutional investors, including AstraZeneca (<a href=\"https://seekingalpha.com/symbol/AZN\" title=\"AstraZeneca Group plc\">AZN</a> <font color=\"red\">-0.1%</font>) will invest $10M in the new organization.</li>\n<li>Under the terms of the deal, Biodel shareholders will own ~33% of the combined firm while Albireo shareholders will own ~67%. Albireo chief Ron Cooper will be serve as President &amp; CEO of Albireo Pharma while Chairman David Chiswell, Ph.D,, will continue as Chairman. The transaction should close in Q3.</li>\n<li>The combined firm will focus on developing bile acid modulators for the treatment of a range of liver, gastrointestinal and other disorders. Albireo's lead product candidate is Phase 2-stage <a href=\"http://www.albireopharma.com/programs/a4250-program/\" target=\"_blank\">A4250</a> for the treatment of a pediatric orphan disease called <a href=\"https://ghr.nlm.nih.gov/condition/progressive-familial-intrahepatic-cholestasis\" target=\"_blank\">Progressive Familial Intrahepatic Cholestasis</a>, an inherited disorder characterized by the buildup of bile in the liver which usually leads to liver failure.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3185854\" data-linked=\"Biodel completes round trip related to Albireo merger; shares down 14%\" data-tweet=\"$ALBO $ALBO $AZN - Biodel completes round trip related to Albireo merger; shares down 14% https://seekingalpha.com/news/3185854-biodel-completes-round-trip-related-to-albireo-merger-shares-down-14?source=tweet\" data-url=\"https://seekingalpha.com/news/3185854-biodel-completes-round-trip-related-to-albireo-merger-shares-down-14\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3185858\" data-ts=\"1464277093\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANF\" target=\"_blank\">ANF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3185858-abercrombie-fitch-slumps-to-six-month-low-after-weak-q1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Abercrombie &amp; Fitch slumps to six-month low after weak Q1</a></h4><ul> <li>Weak Q1 numbers from Abercrombie &amp; Fitch (NYSE:<a href=\"https://seekingalpha.com/symbol/ANF\" title=\"Abercrombie &amp; Fitch\">ANF</a>) send shares into a tailspin.</li> <li>Comparable-store sales were flat at Hollister, but fell 8% at Abercombie brand stores. Management called out \"significant\" traffic headwinds in the U.S. and abroad.</li> <li>Guidance from A&amp;F is for a back-half improvement in comparable-store sales (nothing specific) and for a slight improvement in full-year gross margin rate.</li> <li>Shares of ANF are <font color=\"red\">down 17.4%</font> to a six-month low of $20.70.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3185762-abercrombie-and-fitch-misses-0_08-misses-revenue\" target=\"_blank\">Abercrombie &amp; Fitch misses by $0.08, misses on revenue</a> (May 26)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3185858\" data-linked=\"Abercrombie &amp; Fitch slumps to six-month low after weak Q1\" data-tweet=\"$ANF - Abercrombie &amp; Fitch slumps to six-month low after weak Q1 https://seekingalpha.com/news/3185858-abercrombie-fitch-slumps-to-six-month-low-after-weak-q1?source=tweet\" data-url=\"https://seekingalpha.com/news/3185858-abercrombie-fitch-slumps-to-six-month-low-after-weak-q1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:38 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3185851\" data-ts=\"1464275722\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ETSY\" target=\"_blank\">ETSY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3185851-etsyplus-3-maxim-now-in-bull-camp\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Etsy +3% with Maxim now in the bull camp</a></h4><ul> <li>Shares of Etsy (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ETSY\" title=\"Etsy, Inc.\">ETSY</a>) move <font color=\"green\">up 3%</font> after Maxim Group steps in with an <a href=\"http://www.marketbeat.com/stocks/NASDAQ/ETSY/\" target=\"_blank\">initiation</a> at Buy.</li> <li>The investment firm assigns a price target of $12 to Etsy which is the highest on Wall Street other than Brean Capital's lofty $20 PT. Roth Capital holds down the fort on the bearish side with a $6 PT, while on Seeking Alpha there's a <a href=\"https://seekingalpha.com/article/3972058-etsy-problems\" target=\"_blank\">cautious article</a> from L&amp;F Capital Management that shouldn't be overlooked.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3185851\" data-linked=\"Etsy +3% with Maxim now in the bull camp\" data-tweet=\"$ETSY - Etsy +3% with Maxim now in the bull camp https://seekingalpha.com/news/3185851-etsyplus-3-maxim-now-in-bull-camp?source=tweet\" data-url=\"https://seekingalpha.com/news/3185851-etsyplus-3-maxim-now-in-bull-camp\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:15 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3185849\" data-ts=\"1464275609\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EXTN\" target=\"_blank\">EXTN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3185849-exterran-gets-nyse-non-compliance-notice-over-10-q-filing-delay\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Exterran gets NYSE non-compliance notice over 10-Q filing delay</a></h4><ul>     <li>Exterran (<a href=\"https://seekingalpha.com/symbol/EXTN\" title=\"Exterran Corporation\">EXTN</a> <font color=\"red\">-1.9%</font>) is lower after receiving a non-compliance warning from the NYSE for failure to timely file its 10-Q, which could endanger its listing on the exchange later this year.</li>     <li>EXTN said <a href=\"https://seekingalpha.com/news/3175712-exterran-restate-2015-financial-statements-delay-q1-filing\" target=\"_blank\">last month</a> that would restate its 2015 financial statements and delay filing its Q1 10-Q, as it was investigating financial errors with its Belleli Energy subsidiary, which operates primarily in the Middle East; the company has not yet provided additional details on the internal investigation.</li>     <li>EXTN has until Nov. 16 to return to NYSE compliance in order to maintain its stock listing.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3185849\" data-linked=\"Exterran gets NYSE non-compliance notice over 10-Q filing delay\" data-tweet=\"$EXTN - Exterran gets NYSE non-compliance notice over 10-Q filing delay https://seekingalpha.com/news/3185849-exterran-gets-nyse-non-compliance-notice-over-10-q-filing-delay?source=tweet\" data-url=\"https://seekingalpha.com/news/3185849-exterran-gets-nyse-non-compliance-notice-over-10-q-filing-delay\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3185847\" data-ts=\"1464275254\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RUBI\" target=\"_blank\">RUBI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3185847-rubicon-projectminus-10_6-after-cfo-exit-company-reiterates-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rubicon Project -10.6% after CFO exit; company reiterates guidance</a></h4><ul>     <li>Rubicon Project (NYSE:<a href=\"https://seekingalpha.com/symbol/RUBI\" title=\"The Rubicon Project, Inc.\">RUBI</a>) is continuing a slide from last night's postmarket, now <font color=\"red\">down 10.6%</font> after news that the company's CFO was <a href=\"https://seekingalpha.com/news/3185679-rubicon-project-cfo-tappin-resigns-take-new-job\" target=\"_blank\">departing for another job</a>.</li>     <li>The company also reiterated is guidance for Q2 and the full year, after it spoke yesterday at the B. Riley investor conference.</li>     <li>Earlier this month, the company forecast Q2 EPS of $0.08-$0.10 (vs. consensus for $0.10) and revenues of $61M-$64M (vs. $63.6M consensus). For the full year, it sees EPS of $0.75-$0.85, light of consensus for $0.90, and revenues of $275M-$295M vs. consensus for $295.3M.</li>     <li><a href=\"http://www.wsw.com/webcast/brileyco17/register.aspx?conf=brileyco17&amp;page=rubi&amp;url=http://www.wsw.com/webcast/brileyco17/rubi/index.aspx\" target=\"_blank\">Audio of Rubicon Project fireside chat</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3185847\" data-linked=\"Rubicon Project -10.6% after CFO exit; company reiterates guidance\" data-tweet=\"$RUBI - Rubicon Project -10.6% after CFO exit; company reiterates guidance https://seekingalpha.com/news/3185847-rubicon-projectminus-10_6-after-cfo-exit-company-reiterates-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3185847-rubicon-projectminus-10_6-after-cfo-exit-company-reiterates-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:07 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3185846\" data-ts=\"1464274953\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GIII\" target=\"_blank\">GIII</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3185846-g-iii-apparel-stoked-pvh-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">G-III Apparel stoked by PVH earnings</a></h4><ul> <li>G-III Apparel (<a href=\"https://seekingalpha.com/symbol/GIII\" title=\"G-III Apparel Group, LTD.\">GIII</a> <font color=\"green\">+3.4%</font>) rallies after PVH reports earnings and updates on guidance.</li> <li>PVH licenses Tommy Hilger men's and women's products in the U.S. and Canada to G-III which ties the two companies together to a degree.</li>\n<li>The numbers from the Tommy Hilfiger business were solid in Q1.</li> <li>Shares of G-III Apparel are still down 14% YTD.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3185641-phillips-van-heusen-beats-0_07-beats-revenue\" target=\"_blank\">Phillips-Van Heusen beats by $0.07, beats on revenue</a> (May 25)</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3185793-pvh-rallies-guidance-lift\" target=\"_blank\">PVH rallies after guidance lift</a> (May 26)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3185846\" data-linked=\"G-III Apparel stoked by PVH earnings\" data-tweet=\"$GIII - G-III Apparel stoked by PVH earnings https://seekingalpha.com/news/3185846-g-iii-apparel-stoked-pvh-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3185846-g-iii-apparel-stoked-pvh-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3185820\" data-ts=\"1464274897\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3185820-healthcare-top-5-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/NERV' title='Minerva Neurosciences'>NERV</a> <font color='green'>+155%</font>. <a href='https://seekingalpha.com/symbol/FLXN' title='Flexion Therapeutics, Inc.'>FLXN</a> <font color='green'>+28%</font>. EBIO <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/MLSS' title='Milestone Scientific Inc.'>MLSS</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/ALNY' title='Alnylam Pharmaceuticals, Inc.'>ALNY</a> <font color='green'>+10%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/IONS' title='Ionis Pharmaceuticals, Inc.'>IONS</a> <font color='red'>-32%</font>. <a href='https://seekingalpha.com/symbol/OVAS-OLD' title='OvaScience, Inc.'>OVAS-OLD</a> <font color='red'>-25%</font>. <a href='https://seekingalpha.com/symbol/GBSN-OLD' title='Great Basin Scientific, Inc.'>GBSN</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/KOOL' title='Cesca Therapeutics Inc'>KOOL</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/ALDX' title='Aldeyra Therapeutics, Inc.'>ALDX</a> <font color='red'>-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3185820\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am\" data-tweet=\"$NERV $FLXN $SESN - Healthcare - Top 5 Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3185820-healthcare-top-5-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3185820-healthcare-top-5-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3185833\" data-ts=\"1464272710\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GCO\" target=\"_blank\">GCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3185833-genescoplus-10-after-profit-holds-up-in-q1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Genesco +10% after profit holds up in Q1</a></h4><ul>     <li>Genesco (NYSE:<a href=\"https://seekingalpha.com/symbol/GCO\" title=\"Genesco Inc.\">GCO</a>) pops after topping Q1 profit estimates and reaffirming FY17 guidance.</li>     <li>Genesco expects EPS of $4.80 to $4.90 and comparable sales growth of 1% to 2% for the full year.</li>     <li>During Q1, a \"meaningful\" improvement in gross margin was realized, although the apparel seller didn't break out details.</li>     <li>Shares of Genesco are <font color=\"green\">up 10.2% </font> to $64.19 to help erase part of the spring slide amid broad retail anxiety.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3185731-genesco-beats-0_23-misses-revenue\" target=\"_blank\">Genesco beats by $0.23, misses on revenue</a> (May 26)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3185833\" data-linked=\"Genesco +10% after profit holds up in Q1\" data-tweet=\"$GCO - Genesco +10% after profit holds up in Q1 https://seekingalpha.com/news/3185833-genescoplus-10-after-profit-holds-up-in-q1?source=tweet\" data-url=\"https://seekingalpha.com/news/3185833-genescoplus-10-after-profit-holds-up-in-q1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3185828\" data-ts=\"1464271970\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EWP\" target=\"_blank\">EWP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3185828-spains-banco-popular-crumbles-on-capital-raise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Spain&#39;s Banco Popular crumbles on capital raise</a></h4><ul>\n<li>Banco Popular is <font color=\"red\">lower by 23.9%</font> after launching a <a href=\"http://www.marketwatch.com/story/banco-popular-down-23-on-28-bln-share-sale-news-2016-05-26\" target=\"_blank\">plan to raise \u20ac2.5B</a> through a rights issue to be priced at \u20ac1.25 each vs. Wednesday's close of \u20ac2.36. Shares are currently at \u20ac1.79.</li>\n<li>The new equity should allow an increase in the bank's capital ratio to 10.8% by year-end.</li>\n<li>Spain's IBEX is the worst performer among major European markets today, <font color=\"red\">lower by 0.8%</font>. <a href=\"https://seekingalpha.com/symbol/EWP\" title=\"iShares MSCI Spain Capped ETF\">EWP</a><font color=\"red\"> -0.5%</font>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3185828\" data-linked=\"Spain&#39;s Banco Popular crumbles on capital raise\" data-tweet=\"$EWP - Spain&#39;s Banco Popular crumbles on capital raise https://seekingalpha.com/news/3185828-spains-banco-popular-crumbles-on-capital-raise?source=tweet\" data-url=\"https://seekingalpha.com/news/3185828-spains-banco-popular-crumbles-on-capital-raise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:12 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3185823\" data-ts=\"1464271072\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OXLC\" target=\"_blank\">OXLC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3185823-oxford-lane-capital-slides-after-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oxford Lane Capital slides after downgrade</a></h4><ul>\n<li>Oxford Lane Capital (<a href=\"https://seekingalpha.com/symbol/OXLC\" title=\"Oxford Lane Capital\">OXLC</a> <font color=\"red\">-3.3%</font>) has been under pressure since announcing another sizable drop in NAV last week - to $7.04 per share as of March 31 vs. $8.13 three months earlier. The current price of $9.10 is 1.3x NAV.</li>\n<li>Maxim Group downgrades to Sell from Hold.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3185823\" data-linked=\"Oxford Lane Capital slides after downgrade\" data-tweet=\"$OXLC - Oxford Lane Capital slides after downgrade https://seekingalpha.com/news/3185823-oxford-lane-capital-slides-after-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3185823-oxford-lane-capital-slides-after-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3185816\" data-ts=\"1464270300\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GBSN\" target=\"_blank\">GBSN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3185816-great-basin-commences-equity-6m-equity-offering-shares-slump-13\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Great Basin commences equity $6M equity offering; shares slump 13%</a></h4><ul>\n<li>Great Basin Scientific (<a href=\"https://seekingalpha.com/symbol/GBSN-OLD\" title=\"Great Basin Scientific, Inc.\">GBSN</a> <font color=\"red\">-13.4%</font>) is down on increased volume in response to its announcement of a public offering of 3.16M units at $1.90 per unit. Each unit consists of one share of common stock and one five-year Series G warrant to purchase one share of common at $1.90, subject to adjustment (the company will reduce the exercise price if the share price fails to surmount $1.90).</li>\n<li>Net proceeds of ~$5.2M will fund R&amp;D, sales and marketing activities, manufacturing of additional analyzers, the expansion of manufacturing capacity, working capital and general corporate purposes. Closing date is June 1.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3185816\" data-linked=\"Great Basin commences equity $6M equity offering; shares slump 13%\" data-tweet=\"$GBSN $GBSN-OLD - Great Basin commences equity $6M equity offering; shares slump 13% https://seekingalpha.com/news/3185816-great-basin-commences-equity-6m-equity-offering-shares-slump-13?source=tweet\" data-url=\"https://seekingalpha.com/news/3185816-great-basin-commences-equity-6m-equity-offering-shares-slump-13\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3185810\" data-ts=\"1464269244\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NFLX\" target=\"_blank\">NFLX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3185810-ft-apple-exec-proposed-time-warner-bid-netflixplus-3_7-on-link\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FT: Apple exec proposed Time Warner bid; Netflix +3.7% on link</a></h4><ul>   <li>Netflix (NASDAQ:<a href=\"https://seekingalpha.com/symbol/NFLX\" title=\"Netflix, Inc.\">NFLX</a>) is <font color=\"green\">up 3.7%</font> premarket, and Time Warner (NYSE:<a href=\"https://seekingalpha.com/symbol/TWX\" title=\"Time Warner Inc.\">TWX</a>) <font color=\"green\">up 0.9%</font>, after the two were linked as takeover targets in a story about Apple's (NASDAQ:<a href=\"https://seekingalpha.com/symbol/AAPL\" title=\"Apple Inc.\">AAPL</a>) content ambitions.</li>    <li>The <i>Financial Times</i> reports that Apple exec Eddy Cue <a href=\"http://www.ft.com/intl/cms/s/0/a3bf618a-22ec-11e6-9d4d-c11776a5124d.html\" target=\"_blank\">raised the idea of buying Time Warner</a> at a meeting with the company's head of corporate strategy at the end of last year.</li>    <li>Those ideas didn't get to Apple chief Tim Cook or Time Warner CEO Jeff Bewkes, sources told the <i>FT,</i> but the story does suggest Apple may not be content just talking about licensing others' content for a future TV service.</li>    <li>Meanwhile, several bankers suggest to the <i>FT</i> that Netflix is a more likely target for Apple, since an Apple service could then still support a wider range of content makers.</li>    <li>Several media companies would be bad targets for Apple because of dual-share structures that favor founders or family ownership (like Comcast, Fox, CBS, and Viacom). Notable exceptions to that concern are Time Warner and Walt Disney (NYSE:<a href=\"https://seekingalpha.com/symbol/DIS\" title=\"The Walt Disney Company\">DIS</a>).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3185810\" data-linked=\"FT: Apple exec proposed Time Warner bid; Netflix +3.7% on link\" data-tweet=\"$NFLX $NFLX $TWX - FT: Apple exec proposed Time Warner bid; Netflix +3.7% on link https://seekingalpha.com/news/3185810-ft-apple-exec-proposed-time-warner-bid-netflixplus-3_7-on-link?source=tweet\" data-url=\"https://seekingalpha.com/news/3185810-ft-apple-exec-proposed-time-warner-bid-netflixplus-3_7-on-link\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>50&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3185809\" data-ts=\"1464269150\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FLXN\" target=\"_blank\">FLXN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3185809-fda-ok-flexions-data-supporting-nda-filing-for-lead-product-candidate-zilretta-submission-on\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA OK with Flexion&#39;s data supporting NDA filing for lead product candidate Zilretta, submission on track for Q4; shares up 18% premarket</a></h4><ul>\n<li>Thinly traded micro cap Flexion Therapeutics (NASDAQ:<a href=\"https://seekingalpha.com/symbol/FLXN\" title=\"Flexion Therapeutics, Inc.\">FLXN</a>) is up <font color=\"green\">18%</font> premarket on light volume in response to its announcement that the FDA informed the company that its safety and efficacy data from clinical studies assessing lead product candidate, Fast Track-tagged Zilretta (FX006), for the treatment of pain associated with osteoarthritis of the knee are acceptable to support a New Drug Application (NDA). The agency's written feedback obviates the need for an in-person pre-NDA meeting and clears the way for an NDA filing in Q4.</li>\n<li>\n<a href=\"http://flexiontherapeutics.com/\" target=\"_blank\">Zilretta</a> is an intra-articular injection based on microsphere technology that combines a polymer with a corticosteroid to provide long-term pain relief.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3185809\" data-linked=\"FDA OK with Flexion&#39;s data supporting NDA filing for lead product candidate Zilretta, submission on track for Q4; shares up 18% premarket\" data-tweet=\"$FLXN - FDA OK with Flexion&#39;s data supporting NDA filing for lead product candidate Zilretta, submission on track for Q4; shares up 18% premarket https://seekingalpha.com/news/3185809-fda-ok-flexions-data-supporting-nda-filing-for-lead-product-candidate-zilretta-submission-on?source=tweet\" data-url=\"https://seekingalpha.com/news/3185809-fda-ok-flexions-data-supporting-nda-filing-for-lead-product-candidate-zilretta-submission-on\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3185805\" data-ts=\"1464268708\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3185805-premarket-gainers-losers-of-9-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers as of 9:10 am</a></h4><ul> <li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/NERV\" title=\"Minerva Neurosciences\">NERV</a> <font color=\"green\">+260%</font>. <a href=\"https://seekingalpha.com/symbol/MGT\" title=\"MGT Capital Investments Inc\">MGT</a> <font color=\"green\">+16%</font>. LGF <font color=\"green\">+10%</font>. <a href=\"https://seekingalpha.com/symbol/FMSA\" title=\"Fairmount Santrol, Inc.\">FMSA</a> <font color=\"green\">+9%</font>. <a href=\"https://seekingalpha.com/symbol/MT\" title=\"ArcelorMittal\">MT</a> <font color=\"green\">+9%</font>. <a href=\"https://seekingalpha.com/symbol/DLTR\" title=\"Dollar Tree, Inc.\">DLTR</a> <font color=\"green\">+9%</font>. <a href=\"https://seekingalpha.com/symbol/AKS\" title=\"AK Steel Holding Corp\">AKS</a> <font color=\"green\">+8%</font>. <a href=\"https://seekingalpha.com/symbol/SYNC\" title=\"Synacor\">SYNC</a> <font color=\"green\">+8%</font>. <a href=\"https://seekingalpha.com/symbol/SDLP\" title=\"Seadrill Partners, LLC\">SDLP</a> <font color=\"green\">+7%</font>. <a href=\"https://seekingalpha.com/symbol/BCEI\" title=\"Bonanza Creek Energy\">BCEI</a> <font color=\"green\">+7%</font>. <a href=\"https://seekingalpha.com/symbol/PVH\" title=\"PVH Corp.\">PVH</a> <font color=\"green\">+6%</font>. <a href=\"https://seekingalpha.com/symbol/X\" title=\"United States Steel Corporation\">X</a> <font color=\"green\">+6%</font>. <a href=\"https://seekingalpha.com/symbol/SDRL\" title=\"Seadrill Limited (New)\">SDRL</a> <font color=\"green\">+6%</font>. <a href=\"https://seekingalpha.com/symbol/CHK\" title=\"Chesapeake Energy Corporation\">CHK</a> <font color=\"green\">+6%</font>. <a href=\"https://seekingalpha.com/symbol/CLF\" title=\"Cleveland-Cliffs, Inc.\">CLF</a> <font color=\"green\">+6%</font>. <a href=\"https://seekingalpha.com/symbol/BURL\" title=\"Burlington Stores, Inc\">BURL</a> <font color=\"green\">+6%</font>.</li> <li>\n<b>Losers:</b> PRGN <font color=\"red\">-45%</font>. <a href=\"https://seekingalpha.com/symbol/OVAS-OLD\" title=\"OvaScience, Inc.\">OVAS-OLD</a> <font color=\"red\">-24%</font>. <a href=\"https://seekingalpha.com/symbol/TDW\" title=\"Tidewater, Inc.\">TDW</a> <font color=\"red\">-23%</font>. <a href=\"https://seekingalpha.com/symbol/PSTG\" title=\"Pure Storage\">PSTG</a> <font color=\"red\">-21%</font>. <a href=\"https://seekingalpha.com/symbol/IONS\" title=\"Ionis Pharmaceuticals, Inc.\">IONS</a> <font color=\"red\">-16%</font>. <a href=\"https://seekingalpha.com/symbol/GBSN-OLD\" title=\"Great Basin Scientific, Inc.\">GBSN</a> <font color=\"red\">-14%</font>. <a href=\"https://seekingalpha.com/symbol/ANF\" title=\"Abercrombie &amp; Fitch\">ANF</a> <font color=\"red\">-11%</font>. <a href=\"https://seekingalpha.com/symbol/ALDX\" title=\"Aldeyra Therapeutics, Inc.\">ALDX</a> <font color=\"red\">-9%</font>. <a href=\"https://seekingalpha.com/symbol/CLRB\" title=\"Cellectar Biosciences, Inc.\">CLRB</a> <font color=\"red\">-7%</font>. <a href=\"https://seekingalpha.com/symbol/NTAP\" title=\"NetApp, Inc.\">NTAP</a> <font color=\"red\">-7%</font>. <a href=\"https://seekingalpha.com/symbol/CHS\" title=\"Chico's FAS, Inc.\">CHS</a> <font color=\"red\">-6%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3185805\" data-linked=\"Premarket Gainers / Losers as of 9:10 am\" data-tweet=\"$NERV $MGT $LGF.A - Premarket Gainers / Losers as of 9:10 am https://seekingalpha.com/news/3185805-premarket-gainers-losers-of-9-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3185805-premarket-gainers-losers-of-9-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3185802\" data-ts=\"1464268241\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JACK\" target=\"_blank\">JACK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3185802-jack-in-box-in-spotlight-after-stirring-analyst-day\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jack in the Box in the spotlight after stirring analyst day</a></h4><ul> <li>Investment firms are weighing in favorably on Jack in the Box (NASDAQ:<a href=\"https://seekingalpha.com/symbol/JACK\" title=\"Jack In The Box Inc.\">JACK</a>) after the company impressed during its investor day event yesterday.</li> <li>Robert W. Baird <a href=\"https://twitter.com/Briefingcom/status/735798160937783296\" target=\"_blank\">upgrades</a> the restaurant stock to Outperform from Neutral.</li> <li>Cowen and Company takes its price target on JACK to $94 and Barclays moves to a PT of $86.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3185563-jack-box-rallies-investor-day-meeting-full-swing\" target=\"_blank\">Jack in the Box rallies with investor day meeting in full swing</a> (May 25)</li> <li>JACK <font color=\"green\">+1.20%</font> premarket to $80.00.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3185802\" data-linked=\"Jack in the Box in the spotlight after stirring analyst day\" data-tweet=\"$JACK - Jack in the Box in the spotlight after stirring analyst day https://seekingalpha.com/news/3185802-jack-in-box-in-spotlight-after-stirring-analyst-day?source=tweet\" data-url=\"https://seekingalpha.com/news/3185802-jack-in-box-in-spotlight-after-stirring-analyst-day\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3185800\" data-ts=\"1464268137\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NERV\" target=\"_blank\">NERV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3185800-minerva-neuros-lead-product-candidate-successful-in-mid-stage-schizophrenia-study-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Minerva Neuro&#39;s lead product candidate successful in mid-stage schizophrenia study; shares rocket up 255% premarket</a></h4><ul>\n<li>A Phase 2b clinical trial assessing Minerva Neurosciences' (NASDAQ:<a href=\"https://seekingalpha.com/symbol/NERV\" title=\"Minerva Neurosciences\">NERV</a>) lead product candidate, MIN-101, in patients with negative symptoms of schizophrenia <a href=\"https://www.sec.gov/Archives/edgar/data/1598646/000119312516603149/d195785dex991.htm\" target=\"_blank\">met its primary endpoint</a> of a statistically valid improvement over placebo in improving negative symptoms.</li>\n<li>The effect, statistically significant for both the 32 mg and 64 mg doses, was measured by the pentagonal structure model (PSM) of the Positive and Negative Syndrome Scale (PANSS). Only the 64 mg dose achieved statistical significance as measured by PANSS total score, however.</li>\n<li>\n<a href=\"http://minervaneurosciences.com/\" target=\"_blank\">MIN-101</a> was safe and well-tolerated with no significant difference in side effects compared to placebo. Two patients out of the 162 (1.2%) who received MIN-101 discontinued treatment due to changes in a cardiac function metric called QTcF prolongation. Both were in the 64 mg cohort. No weight gain or extra-pyramidal symptoms were observed.</li>\n<li>Patients who completed the 12-week double-blind core phase of the trial were given the option to participate in a 24-week open-label extension phase during which they will receive either 32 mg or 64 mg of MIN-101. The extension phase should be completed in Q3.</li>\n<li>Negative symptoms comprise the main burden for schizophrenia sufferers because they are responsible for poor vocational and psychosocial functioning. These symptoms include lack of motivation and initiative and restricted personal interaction.</li>\n<li>The development of MIN-101, which principally binds to the receptors 5-HT2A and sigma 2, is ongoing.</li>\n<li>Shares are up <font color=\"green\">255%</font> premarket on robust volume.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3185800\" data-linked=\"Minerva Neuro&#39;s lead product candidate successful in mid-stage schizophrenia study; shares rocket up 255% premarket\" data-tweet=\"$NERV - Minerva Neuro&#39;s lead product candidate successful in mid-stage schizophrenia study; shares rocket up 255% premarket https://seekingalpha.com/news/3185800-minerva-neuros-lead-product-candidate-successful-in-mid-stage-schizophrenia-study-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3185800-minerva-neuros-lead-product-candidate-successful-in-mid-stage-schizophrenia-study-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3185798\" data-ts=\"1464267814\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FRED\" target=\"_blank\">FRED</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3185798-on-freds-q1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Fred&#39;s Q1</a></h4><ul>     <li>Fred's (<a href=\"https://seekingalpha.com/symbol/FRED\" title=\"Fred's, Inc.\">FRED</a>) reports comparable-store sales rose 1% in Q1.</li>     <li>Gross margin rate dropped 120 bps to 25.7%.</li>     <li>Adjusted SG&amp;A expense rate improved 170 bps to 25.2% due to controlled labor within the pharmacy department, lowered occupancy costs and improved supply chain efficiencies.</li>     <li>Adjusted EBITDA increased 35.4% to $15.7M for the period.</li>     <li>\n<b>Q2 Guidance</b>: Total sales: flat to +2%; Comparable-store sales: flat to +2%; Adjusted EBITDA : $14M to $17M (+90% to +130%); Diluted EPS: flat to $0.03.</li>     <li>\n<b>FY2016 Guidance</b>: Total sales: +2% to +6%; Comparable-store sales: +1% to +4%; Adjusted EBITDA : $73M to $78M (+35% to +45%); Diluted EPS: $0.27 to $0.32.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3185798\" data-linked=\"More on Fred&#39;s Q1\" data-tweet=\"$FRED - More on Fred&#39;s Q1 https://seekingalpha.com/news/3185798-on-freds-q1?source=tweet\" data-url=\"https://seekingalpha.com/news/3185798-on-freds-q1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:03 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3185793\" data-ts=\"1464267572\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PVH\" target=\"_blank\">PVH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3185793-pvh-rallies-after-guidance-lift\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PVH rallies after guidance lift</a></h4><ul> <li>PVH (NYSE:<a href=\"https://seekingalpha.com/symbol/PVH\" title=\"PVH Corp.\">PVH</a>) shoots higher after the company raised its full-year EPS forecast after a better-than-expected Q1.</li>\n<li>Calvin Klein was a strong performer during the quarter, with revenue up 13% before foreign exchange was factored in. Sales at Tommy Hilfiger were up 4% ex-F/X.</li> <li>The company expects EPS of $6.45-$6.55 vs. $6.30-$6.50 prior and $6.46 consensus.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3185641-phillips-van-heusen-beats-0_07-beats-revenue\" target=\"_blank\">Phillips-Van Heusen beats by $0.07, beats on revenue</a> (May 25)</li> <li>PVH <font color=\"green\">+6.47%</font> premarket to $95.60.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3185793\" data-linked=\"PVH rallies after guidance lift\" data-tweet=\"$PVH - PVH rallies after guidance lift https://seekingalpha.com/news/3185793-pvh-rallies-after-guidance-lift?source=tweet\" data-url=\"https://seekingalpha.com/news/3185793-pvh-rallies-after-guidance-lift\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3185792\" data-ts=\"1464267382\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SDRL\" target=\"_blank\">SDRL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3185792-seadrill-q1-profits-revenues-plunge-scores-record-operational-uptime\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Seadrill Q1 profits, revenues plunge but scores &quot;record operational uptime&quot;</a></h4><ul>     <li>Seadrill (NYSE:<a href=\"https://seekingalpha.com/symbol/SDRL\" title=\"Seadrill Limited (New)\">SDRL</a>) <font color=\"green\">+5%</font> premarket after its <a href=\"https://seekingalpha.com/news/3185718-seadrill-eps-0_15\" target=\"_blank\">Q1 earnings</a> report included plans to <a href=\"http://www.marketwatch.com/story/seadrill-profit-slides-on-lower-rates-for-rigs-2016-05-26\" target=\"_blank\">cut costs by $340M</a> this year, with $305M considered sustainable savings and $35M deferred spending; SDRL previously had said it planned to cut costs by $260M.</li>     <li>SDRL, whose Q1 revenues tumbled 28% Y/Y to $891M from $1.2B in the year-ago period, partly because of lower dayrates paid for some of its drilling rigs, says it had \"record operational uptime\" with 96% economic utilization.</li>\n<li>SDRL CEO Per Wullf thinks the rig market will rebalance eventually: \"Within the next few  years, we believe the continued scrapping of older rigs in combination  with required exploration and development drilling will bring the market  back to balance and subsequent improved day rates.\"</li>\n<li>Now read <a href=\"https://seekingalpha.com/article/3977915-seadrill-upside-sorry\" target=\"_blank\"><strong>Seadrill: No upside, sorry</strong></a>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"3185792\" data-linked=\"Seadrill Q1 profits, revenues plunge but scores &quot;record operational uptime&quot;\" data-tweet=\"$SDRL - Seadrill Q1 profits, revenues plunge but scores &quot;record operational uptime&quot; https://seekingalpha.com/news/3185792-seadrill-q1-profits-revenues-plunge-scores-record-operational-uptime?source=tweet\" data-url=\"https://seekingalpha.com/news/3185792-seadrill-q1-profits-revenues-plunge-scores-record-operational-uptime\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3185789\" data-ts=\"1464266736\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QSR\" target=\"_blank\">QSR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3185789-popeyes-louisiana-kitchen-slips-after-results-disappoint\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Popeyes Louisiana Kitchen slips after results disappoint</a></h4><ul> <li>Popeyes Louisiana Kitchen (PLKI) trades lower after the company misses estimates with its Q1 report.</li> <li>The company cited a \"very promotional\" QSR landscape during the quarter, but still managed a 1.6% gain in global same-store sales.</li> <li>Popeyes increased its market share in the chicken-QSR category to 26.3% vs. 24.6% a year ago.</li> <li>Operating EBITDA as a percentage of revenue fell 240 bps to 30.4% with some planned strategic investments a factor.</li> <li>Looking ahead, Popeyes expects FY16 EPS of $2.10 to $2.15 vs. $2.14 consensus.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3185628-popeyes-louisiana-kitchen-misses-0_06-misses-revenue\" target=\"_blank\">Popeyes Louisiana Kitchen misses by $0.06, misses on revenue</a> (May 25)</li> <li>PLKI <font color=\"red\">-4.10%</font> premarket to $50.00.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3185789\" data-linked=\"Popeyes Louisiana Kitchen slips after results disappoint\" data-tweet=\"$QSR - Popeyes Louisiana Kitchen slips after results disappoint https://seekingalpha.com/news/3185789-popeyes-louisiana-kitchen-slips-after-results-disappoint?source=tweet\" data-url=\"https://seekingalpha.com/news/3185789-popeyes-louisiana-kitchen-slips-after-results-disappoint\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:45 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3185781\" data-ts=\"1464265780\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVET\" target=\"_blank\">NVET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3185781-nexvet-bios-ngf-monoclonal-antibody-shows-effective-pain-control-in-field-study-of-cats\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nexvet Bio&#39;s NGF monoclonal antibody shows effective pain control in field study of cats with osteoarthritis; shares up 13% premarket</a></h4><ul>\n<li>Ultra-thinly traded nano cap Nexvet Biopharma (NASDAQ:<a href=\"https://seekingalpha.com/symbol/NVET\" title=\"Nexvet Biopharma\">NVET</a>) is up <font color=\"green\">13%</font> premarket on turnover of 6,600 shares in response to its announcement of positive results from a field study assessing product candidate NV-02, an anti-nerve growth factor (NGF) monoclonal antibody, for the treatment of pain in cats suffering from osteoarthritis. NV-02 is being developed as a once/month subcutaneous injection.</li>\n<li>Cats treated with <a href=\"http://www.nexvet.com/therapies/chronic-pain/nv-02/\" target=\"_blank\">NV-02</a> showed statistically valid improvements in pain levels as measured by a scale called Client-Specific Outcome Measures (CSOM) from baseline (enrollment) to day 42 and day 56. There was also a statistically valid difference in the NV-02 group compared to placebo at day 28 and day 56. NV-02 was safe and well-tolerated with no significant adverse safety signals observed.</li>\n<li>The company intends to advance NV-02 to a pivotal efficacy and field safety study later this year.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3185781\" data-linked=\"Nexvet Bio&#39;s NGF monoclonal antibody shows effective pain control in field study of cats with osteoarthritis; shares up 13% premarket\" data-tweet=\"$NVET - Nexvet Bio&#39;s NGF monoclonal antibody shows effective pain control in field study of cats with osteoarthritis; shares up 13% premarket https://seekingalpha.com/news/3185781-nexvet-bios-ngf-monoclonal-antibody-shows-effective-pain-control-in-field-study-of-cats?source=tweet\" data-url=\"https://seekingalpha.com/news/3185781-nexvet-bios-ngf-monoclonal-antibody-shows-effective-pain-control-in-field-study-of-cats\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:29 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3185776\" data-ts=\"1464265160\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AKS\" target=\"_blank\">AKS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3185776-u-s-slaps-hefty-duties-on-chinese-corrosion-resistant-steel\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">U.S. slaps hefty duties on Chinese corrosion-resistant steel</a></h4><ul>     <li>U.S. steel companies surge in premarket trading after the U.S. announced <a href=\"http://www.reuters.com/article/us-usa-trade-steel-idUSKCN0YH00R\" target=\"_blank\">heavy anti-dumping and anti-subsidy duties</a> on corrosion-resistant steel from China, in the latest U.S. clampdown on a glut of steel imports.</li>     <li>The Commerce Department issued duties of as much as 450% on Chinese producers of corrosion-resistant steel, as well as duties of 3%-92% on producers from Italy, India, South Korea and Taiwan.</li>     <li>The final U.S. anti-dumping duties on the Chinese products replace preliminary duties of 256% issued in December.</li>     <li>Last week the Commerce Department issued punitive tariffs of more than 500% on Chinese cold-rolled flat steel.</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/AKS\" title=\"AK Steel Holding Corp\">AKS</a> <font color=\"green\">+7%</font>, <a href=\"https://seekingalpha.com/symbol/X\" title=\"United States Steel Corporation\">X</a> <font color=\"green\">+5.6%</font>, <a href=\"https://seekingalpha.com/symbol/CLF\" title=\"Cleveland-Cliffs, Inc.\">CLF</a> <font color=\"green\">+4.8%</font>, <a href=\"https://seekingalpha.com/symbol/NUE\" title=\"Nucor Corporation\">NUE</a> <font color=\"green\">+2.3%</font>, <a href=\"https://seekingalpha.com/symbol/STLD\" title=\"Steel Dynamics, Inc.\">STLD</a> <font color=\"green\">+1.6%</font> premarket.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3185776\" data-linked=\"U.S. slaps hefty duties on Chinese corrosion-resistant steel\" data-tweet=\"$AKS $AKS $X - U.S. slaps hefty duties on Chinese corrosion-resistant steel https://seekingalpha.com/news/3185776-u-s-slaps-hefty-duties-on-chinese-corrosion-resistant-steel?source=tweet\" data-url=\"https://seekingalpha.com/news/3185776-u-s-slaps-hefty-duties-on-chinese-corrosion-resistant-steel\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3185773\" data-ts=\"1464264483\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MT\" target=\"_blank\">MT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3185773-arcelormittalplus-9-on-signs-eu-trade-case-on-steel-may-widen\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ArcelorMittal +9% on signs EU trade case on steel may widen</a></h4><ul>     <li>ArcelorMittal (NYSE:<a href=\"https://seekingalpha.com/symbol/MT\" title=\"ArcelorMittal\">MT</a>) <font color=\"green\">+9.1%</font> premarket on  speculation that the European Commission <a href=\"http://www.bloomberg.com/news/articles/2016-05-26/arcelormittal-climbs-on-signs-eu-trade-case-on-steel-may-widen\" target=\"_blank\">may extend its anti-dumping  investigation</a> on imports of hot-rolled coil to more countries.</li>     <li>The commission is looking into whether Chinese exporters of hot-rolled coil received trade-distorting government aid as well as whether Chinese exporters sold the type of steel in the EU below cost.</li>\n<li>RBC Capital says the  European Steel Association has petitioned the EC to widen its  investigation beyond China to include Turkey, Russia, Brazil, Iran and  Ukraine, and that MT would benefit the most from a wider EU trade case.</li>\n<li>Now read <a href=\"https://seekingalpha.com/article/3972619-arcelormittal-buy\" target=\"_blank\"><strong>ArcelorMittal is a buy</strong></a>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"3185773\" data-linked=\"ArcelorMittal +9% on signs EU trade case on steel may widen\" data-tweet=\"$MT - ArcelorMittal +9% on signs EU trade case on steel may widen https://seekingalpha.com/news/3185773-arcelormittalplus-9-on-signs-eu-trade-case-on-steel-may-widen?source=tweet\" data-url=\"https://seekingalpha.com/news/3185773-arcelormittalplus-9-on-signs-eu-trade-case-on-steel-may-widen\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3185772\" data-ts=\"1464264369\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DLTR\" target=\"_blank\">DLTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3185772-dollar-tree-higher-post-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dollar Tree higher post Q1 results</a></h4><ul>     <li>Dollar Tree (NASDAQ:<a href=\"https://seekingalpha.com/symbol/DLTR\" title=\"Dollar Tree, Inc.\">DLTR</a>) reports same-store sales rose 2.3% in Q1 due to increases in customer transactions and average ticket.</li>     <li>Gross profit rate slipped 380 bps to 30.6%.</li>     <li>SG&amp;A expense rate improved 90 bps to 22.3% due to lower payroll, operating and corporate expenses.</li>     <li>Operating margin rate squeezed 300 bps to 8.2%.</li>     <li>Store count +8,543 Y/Y to 13997 (includes 7,948 Family Dollar stores).</li>     <li>Retail selling square footage +132.2% to 109.6M.</li>     <li>\n<b>Q2 Guidance</b>: Net sales: $5.03B to $5.12B; Same-store sales: low single-digit increase; Diluted EPS: $0.66 to $0.72; Selling square footage: +2.4% Y/Y.</li>     <li>\n<b>FY2016 Guidance</b>: Net sales: $20.79B to $21.08B; Same-store sales: low single-digit growth; Diluted EPS: $3.58 to $3.80; Selling square footage: +4% Y/Y.</li>     <li>DLTR <font color=\"green\">+6.56%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3185772\" data-linked=\"Dollar Tree higher post Q1 results\" data-tweet=\"$DLTR - Dollar Tree higher post Q1 results https://seekingalpha.com/news/3185772-dollar-tree-higher-post-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3185772-dollar-tree-higher-post-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3185767\" data-ts=\"1464263586\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IONS\" target=\"_blank\">IONS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3185767-glaxo-declines-to-proceed-late-stage-study-of-ionis-pharmas-ionis-ttrrx-ionis-down-7\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Glaxo declines to proceed with late-stage study of Ionis Pharma&#39;s IONIS-TTRrx; Ionis down 7% premarket</a></h4><ul>\n<li>Ionis Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/IONS\" title=\"Ionis Pharmaceuticals, Inc.\">IONS</a>) reports that strategic alliance partner GlaxoSmithKline (NYSE:<a href=\"https://seekingalpha.com/symbol/GSK\" title=\"GlaxoSmithKline\">GSK</a>) has elected not to proceed with a Phase 3 clinical trial, CARDIO-TTR, assessing antisense drug IONIS-TTRrx in patients with transthyretin (TTR) amyloid cardiomyopathy. The trial was placed on clinical hold by the FDA last month due to safety issues identified in Ionis' Phase 3 study, NEURO-TTR, evaluating IONIS-TTRrx in TTR familial amyloid polyneuropathy (FAP). Glaxo says it will evaluate its options once more data are available from ongoing studies.</li>\n<li>\n<a href=\"https://ghr.nlm.nih.gov/condition/transthyretin-amyloidosis\" target=\"_blank\">TTR amyloidosis</a> is a rare inherited condition caused by the abnormal formation and aggregation of TTR amyloid deposits in various tissues and organs. It is slowly progressive and fatal. The exact incidence is unknown but is thought to affect one in 100K people. FAP is characterized by the accumulation of misfolded mutated TTR protein in the peripheral nerves. TTR-related cardiomyopathy is characterized by the accumulation of misfolded TTR protein in cardiac muscle.</li>\n<li>Ionis will host a conference call this morning at 9:00 am ET to update investors on its IONIS-TTRrx program.</li>\n<li>IONS is down <font color=\"red\">7%</font> premarket on light volume.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3171967-glaxos-late-stage-study-ionis-pharmas-ionis-ttrrx-clinical-hold-ionis-shares-11-percent\" target=\"_blank\">Glaxo's late-stage study of Ionis Pharma's IONIS-TTRrx on clinical hold; Ionis shares down 11%</a> (April 7)</li>\n<li>\n<strong>Update</strong>: According to a <a href=\"https://www.thestreet.com/story/13586917/1/why-ionis-pharmaceuticals-ions-stock-is-tanking-today.html?puc=yahoo&amp;cm_ven=YAHOO\" target=\"_blank\">report </a>by JP Morgan, the safety issue is abnormal drops in platelet counts, observed in no more than five patients.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3185767\" data-linked=\"Glaxo declines to proceed with late-stage study of Ionis Pharma&#39;s IONIS-TTRrx; Ionis down 7% premarket\" data-tweet=\"$IONS $IONS $GSK - Glaxo declines to proceed with late-stage study of Ionis Pharma&#39;s IONIS-TTRrx; Ionis down 7% premarket https://seekingalpha.com/news/3185767-glaxo-declines-to-proceed-late-stage-study-of-ionis-pharmas-ionis-ttrrx-ionis-down-7?source=tweet\" data-url=\"https://seekingalpha.com/news/3185767-glaxo-declines-to-proceed-late-stage-study-of-ionis-pharmas-ionis-ttrrx-ionis-down-7\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>47&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3185741\" data-ts=\"1464260916\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BURL\" target=\"_blank\">BURL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3185741-burlington-stores-raises-fy2016-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Burlington Stores raises FY2016 guidance</a></h4><ul>     <li>Burlington Stores (NYSE:<a href=\"https://seekingalpha.com/symbol/BURL\" title=\"Burlington Stores, Inc\">BURL</a>) reports comparable-store sales rose 4.3% in Q1.</li>     <li>Gross margin rate grew 35 bps to 40.1%.</li>     <li>SG&amp;A expense rate improved 60 bps to 26.7%.</li>     <li>Adjusted EBITDA expanded 19.3% to $121M.</li>     <li>Merchandise Inventories -2.1% Y/Y to $804.7M.</li>     <li>\n<b>Q2 Guidance</b>: Net sales: +6.3% to +7.3%; Comparable-store sales: +2.5% to +3.5%; Adjusted diluted EPS: $0.20 to $0.23; Fully diluted share count: ~72.3M.</li>     <li>\n<b>FY2016 Guidance</b>: Net sales: +7.1% to +7.6%; Comparable-store sales: +3% to +3.5%; Adjusted EBITDA margin: +30 bps to +40 bps; Interest expense: ~$62M; Tax rate: ~37.8%; Adjusted diluted EPS: $2.68 to $2.78; Fully diluted share count: ~72.4M; Net new stores: 25.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3185741\" data-linked=\"Burlington Stores raises FY2016 guidance\" data-tweet=\"$BURL - Burlington Stores raises FY2016 guidance https://seekingalpha.com/news/3185741-burlington-stores-raises-fy2016-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3185741-burlington-stores-raises-fy2016-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:08 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3185744\" data-ts=\"1464260882\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DG\" target=\"_blank\">DG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3185744-dollar-general-tracks-higher-after-solid-quarter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dollar General tracks higher after solid quarter</a></h4><ul> <li>Dollar General (NYSE:<a href=\"https://seekingalpha.com/symbol/DG\" title=\"Dollar General Corporation\">DG</a>) reports same-store sales improved by 2.2% in Q1. Traffic and average transaction amount both improved during the quarter.</li> <li>Gross proift as a percentage of profit was up 10 bps to 30.6% with lower transportation costs a positive factor. The SG&amp;A expense rate fell 30 bps to 21.5%.</li> <li>Operating margin rose 42 bps as a higher mix of consumables merchandise helped the bottom line.</li> <li>The company ended the quarter with inventory of $3.07B, up 2% Y/Y.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3185733-dollar-general-beats-0_08-misses-revenue\" target=\"_blank\">Dollar General beats by $0.08, misses on revenue</a> (May 26)</li> <li>DG <font color=\"green\">+2.21%</font> premarket to $86.00. The discounter's 52-week high is $87.42.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3185744\" data-linked=\"Dollar General tracks higher after solid quarter\" data-tweet=\"$DG - Dollar General tracks higher after solid quarter https://seekingalpha.com/news/3185744-dollar-general-tracks-higher-after-solid-quarter?source=tweet\" data-url=\"https://seekingalpha.com/news/3185744-dollar-general-tracks-higher-after-solid-quarter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:08 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3185727\" data-ts=\"1464258800\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DEST\" target=\"_blank\">DEST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3185727-on-destination-maternitys-q1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Destination Maternity&#39;s Q1</a></h4><ul>     <li>Destination Maternity (NASDAQ:<a href=\"https://seekingalpha.com/symbol/DEST\" title=\"Destination Maternity Corporation\">DEST</a>) reports comparable sales decreased 5.4% in Q1 due to lower transactions and unit sales resulting from lower traffic.</li>     <li>Gross margin rate improved 370 bps to 54.1%.</li>     <li>SG&amp;A expense rate grew 200 bps to 47.2%.</li>     <li>Total retail location count -381 Y/Y to 1,487.</li>     <li>\n<b>FY2016 Guidance</b>: Comparable sales: Flat Y/Y; Gross margin rate: ~+200 bps to +300 bps Y/Y; SG&amp;A expense rate: to decline Y/Y; Capex: $15M to $17M.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3185727\" data-linked=\"More on Destination Maternity&#39;s Q1\" data-tweet=\"$DEST - More on Destination Maternity&#39;s Q1 https://seekingalpha.com/news/3185727-on-destination-maternitys-q1?source=tweet\" data-url=\"https://seekingalpha.com/news/3185727-on-destination-maternitys-q1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:33 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3185725\" data-ts=\"1464258257\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHLDQ\" target=\"_blank\">SHLDQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3185725-on-sears-holdings-q1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Sears Holdings&#39; Q1</a></h4><ul>     <li>Sears Holdings (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SHLD\" target=\"_blank\">SHLD</a>) reports comparable-store sales slipped 6.1% in Q1.</li>     <li>Kmart comp fell 5% due to declines in the consumer electronics, grocery &amp; household, pharmacy, drugstore and home categories.</li>     <li>Sears domestic comp dropped 7.1% primarily driven by decreases in home appliances, apparel, consumer electronics, footwear and Sears Auto Centers.</li>     <li>Segment sales: Kmart: $2.139B (-9.2%); Sears Domestic: $3.255B (-7.7%).</li>     <li>Gross margin rate squeezed 400 bps to 21.8%.</li>     <li>Adjusted gross margin rate decreased 180 bps to 22.5%.</li>     <li>SG&amp;A expense rate improved 70 bps to 27.9%.</li>     <li>Adjusted SG&amp;A expense rate fell 80 bps to 25.9%.</li>     <li>Merchandise inventory -0.5% to $5.03B.</li>     <li>Store count -94 Y/Y to 1,622.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3185725\" data-linked=\"More on Sears Holdings&#39; Q1\" data-tweet=\"$SHLDQ - More on Sears Holdings&#39; Q1 https://seekingalpha.com/news/3185725-on-sears-holdings-q1?source=tweet\" data-url=\"https://seekingalpha.com/news/3185725-on-sears-holdings-q1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:24 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3185711\" data-ts=\"1464253914\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3185711-brent-crude-tops-50-per-barrel\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Brent crude tops $50 per barrel</a></h4><ul>\n<li>Recent supply disruptions coupled with growing demand from China and India continue<a href=\"http://www.wsj.com/articles/brent-crude-rises-above-50-a-barrel-1464229441\" target=\"_blank\"> to push oil prices higher</a>, with Brent crude pushing through $50 per barrel in London, and WTI crude just pennies shy of that level in New York.</li>\n<li>Prices are now up about 80% from February, when they hit a 12-year low.</li>\n<li>The latest bullish news was a greater-than-expected inventory build reported by the EIA yesterday.</li>\n<li>The bull market may not last as producers inside of OPEC - Iran in particular - are set to increase output, and wildfire-related Canadian declines are coming to an end.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3185711\" data-linked=\"Brent crude tops $50 per barrel\" data-tweet=\"Brent crude tops $50 per barrel https://seekingalpha.com/news/3185711-brent-crude-tops-50-per-barrel?source=tweet\" data-url=\"https://seekingalpha.com/news/3185711-brent-crude-tops-50-per-barrel\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":60,"message":null,"success":true,"today":{"start":1576990800,"end":1577077199,"str":"Sunday, December 22, 2019"},"yesterday":{"start":1576904400,"end":1576990799}}